1
|
Safia O, Asma J, Hana H, Sarra J, Aymen Z, Mouna J, Amal M, Rym BK. [Infective endocarditis : In-hospital mortality predictive factors]. Ann Cardiol Angeiol (Paris) 2024; 73:101740. [PMID: 38417204 DOI: 10.1016/j.ancard.2024.101740] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2023] [Revised: 01/31/2024] [Accepted: 02/09/2024] [Indexed: 03/01/2024]
Abstract
INTRODUCTION Infective endocarditis (IE) remains a serious disease with significant morbidity and mortality despite therapeutic advancements. The aim of our study was to determine the predictive factors of in-hospital mortality. PATIENTS AND METHODS A prospective comparative study over a period of 54 months was conducted, including all patients admitted for definite infective endocarditis, diagnosed according to the modified Duke criteria published in 2015 by the European Society of Cardiology. RESULTS Thirty-four patients were included. Drug addiction was the main risk factor for infective endocarditis (56%). Tricuspid valve involvement was predominant (50%). Staphylococcus aureus was the most commonly isolated pathogen (65%). In-hospital mortality rate was 47%. In multivariate analysis, predictive factors for mortality were acute heart failure (OR=7.4; p=0.026; 95% CI [1.2-44]) and cerebral embolic localization (OR=11.1; p=0.024; 95% CI [13-90]). CONCLUSIONS Cardiac and cerebral complications influence the prognosis of IE. Thus, close collaboration among multidisciplinary teams is necessary for improved diagnostic and therapeutic management.
Collapse
Affiliation(s)
- Othmani Safia
- Service des urgences, hôpital Charles Nicolle, boulevard 9 Avril 1938 bab saadoun ; 1006 Tunis, Tunisie; Faculté de médecine de Tunis, université Tunis El Manar, Tunisie
| | - Jendoubi Asma
- Service des urgences, hôpital Charles Nicolle, boulevard 9 Avril 1938 bab saadoun ; 1006 Tunis, Tunisie; Faculté de médecine de Tunis, université Tunis El Manar, Tunisie.
| | - Hedhli Hana
- Service des urgences, hôpital Charles Nicolle, boulevard 9 Avril 1938 bab saadoun ; 1006 Tunis, Tunisie; Faculté de médecine de Tunis, université Tunis El Manar, Tunisie
| | - Jouini Sarra
- Service des urgences, hôpital Charles Nicolle, boulevard 9 Avril 1938 bab saadoun ; 1006 Tunis, Tunisie; Faculté de médecine de Tunis, université Tunis El Manar, Tunisie
| | - Zoubli Aymen
- Service des urgences, hôpital Charles Nicolle, boulevard 9 Avril 1938 bab saadoun ; 1006 Tunis, Tunisie; Faculté de médecine de Tunis, université Tunis El Manar, Tunisie
| | - Jemai Mouna
- Service des urgences, hôpital Charles Nicolle, boulevard 9 Avril 1938 bab saadoun ; 1006 Tunis, Tunisie; Faculté de médecine de Tunis, université Tunis El Manar, Tunisie
| | - Maaref Amal
- Service des urgences, hôpital Charles Nicolle, boulevard 9 Avril 1938 bab saadoun ; 1006 Tunis, Tunisie
| | - Ben Kaddour Rym
- Service des urgences, hôpital Charles Nicolle, boulevard 9 Avril 1938 bab saadoun ; 1006 Tunis, Tunisie; Faculté de médecine de Tunis, université Tunis El Manar, Tunisie
| |
Collapse
|
2
|
Gaddour A, Chatti S, Chouchene A, Kacem I, Bouhoula M, Aloui A, Marnaoui M, Maoua M, Brahem A, Kalboussi H, El Maalel O, Mrizek N. [An epidemiological and evolutionary profile of occupational asthma of Tunisian workers]. Rev Mal Respir 2024; 41:227-236. [PMID: 38429194 DOI: 10.1016/j.rmr.2024.02.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2022] [Accepted: 12/16/2023] [Indexed: 03/03/2024]
Abstract
INTRODUCTION This study aims to identify the epidemiological and occupational characteristics of patients with occupational asthma (OA) and to assess their clinical evolution and occupational outcomes. METHODS We carried out a descriptive epidemiological study over a period of five years (from 2012 to 2016) about the OA cases in the private sector reported in the Tunisian region of Zaghouan. RESULTS All in all, 165 OA cases were reported during the study period, representing an annual incidence of 733.3 cases per 1,000,000 workers in the private sector. Our study population was composed predominantly (85.5%) of women, whose mean age was 41.5±6.8years. More than three quarters of the affected persons were working in the automobile industry, and most illnesses (77%) were attributable to isocyanates. The mean time to onset of the respiratory symptoms was longer for low molecular weight agents (13.6±3.1years) compared to high molecular weight agents (12.0±3.9years) (P=0.0006). The majority of OA cases (66.7%) lost their jobs. Job loss was significantly more frequent among asthmatic women and workers with OA due to isocyanates. Among the 62 cases of OA for whom risk factors were eliminated, 45 nonetheless remained symptomatic. CONCLUSION Effective prevention strategies involving the various actors need to be implemented in work environments so as to reduce the frequency and the medico-legal repercussions of a disabling condition.
Collapse
Affiliation(s)
- A Gaddour
- Département de médecine de travail, faculté de médecine de Sousse, université de Sousse, Sousse, Tunisie; Service de médecine de travail et pathologies professionnelles, hôpital universitaire Ibn El Jazzar, Kairouan, Tunisie.
| | - S Chatti
- Département de médecine de travail, faculté de médecine de Sousse, université de Sousse, Sousse, Tunisie; Service de médecine de travail et pathologies professionnelles, hôpital universitaire Farhat Hached, Sousse, Tunisie
| | - A Chouchene
- Département de médecine de travail, faculté de médecine de Sousse, université de Sousse, Sousse, Tunisie; Service de médecine de travail et pathologies professionnelles, hôpital universitaire Farhat Hached, Sousse, Tunisie
| | - I Kacem
- Département de médecine de travail, faculté de médecine de Sousse, université de Sousse, Sousse, Tunisie; Service de médecine de travail et pathologies professionnelles, hôpital universitaire Farhat Hached, Sousse, Tunisie
| | - M Bouhoula
- Département de médecine de travail, faculté de médecine de Sousse, université de Sousse, Sousse, Tunisie; Service de médecine de travail et pathologies professionnelles, hôpital universitaire Farhat Hached, Sousse, Tunisie
| | - A Aloui
- Département de médecine de travail, faculté de médecine de Sousse, université de Sousse, Sousse, Tunisie; Service de médecine de travail et pathologies professionnelles, hôpital universitaire Farhat Hached, Sousse, Tunisie
| | - M Marnaoui
- Inspection médicale de travail, Zaghouan, Tunisie
| | - M Maoua
- Département de médecine de travail, faculté de médecine de Sousse, université de Sousse, Sousse, Tunisie; Service de médecine de travail et pathologies professionnelles, hôpital universitaire Farhat Hached, Sousse, Tunisie
| | - A Brahem
- Département de médecine de travail, faculté de médecine de Sousse, université de Sousse, Sousse, Tunisie; Service de médecine de travail et pathologies professionnelles, hôpital universitaire Farhat Hached, Sousse, Tunisie
| | - H Kalboussi
- Département de médecine de travail, faculté de médecine de Sousse, université de Sousse, Sousse, Tunisie; Service de médecine de travail et pathologies professionnelles, hôpital universitaire Farhat Hached, Sousse, Tunisie
| | - O El Maalel
- Département de médecine de travail, faculté de médecine de Sousse, université de Sousse, Sousse, Tunisie; Service de médecine de travail et pathologies professionnelles, hôpital universitaire Farhat Hached, Sousse, Tunisie
| | - N Mrizek
- Département de médecine de travail, faculté de médecine de Sousse, université de Sousse, Sousse, Tunisie; Service de médecine de travail et pathologies professionnelles, hôpital universitaire Farhat Hached, Sousse, Tunisie
| |
Collapse
|
3
|
Rochoy M, Pontais I, Caserio-Schönemann C, Chan-Chee C, Gainet L, Gobert Y, Baran J, Dodin V, Defebvre L, Collins C, Chazard E, Berkhout C, Balayé P. Pattern of encounters to emergency departments for suicidal attempts in France: Identification of high-risk days, months and holiday periods. Encephale 2024:S0013-7006(24)00008-3. [PMID: 38316568 DOI: 10.1016/j.encep.2023.11.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/25/2023] [Revised: 11/04/2023] [Accepted: 11/08/2023] [Indexed: 02/07/2024]
Abstract
INTRODUCTION Seasonal change in patterns of suicidal attempts is not well known in France and may differ from other western countries. We aimed to determine the peak times (days, months and holiday periods) of suicidal attempts in France. METHODS We carried out a multicentre retrospective epidemiological study, using data from the Organization for Coordinated Monitoring of Emergencies (OSCOUR®) network. We aggregated daily data from January 1, 2010, to December 31, 2019. Variations in suicidal attempts on specific days were investigated by comparing their frequencies (ad hoc Z-scores). RESULTS 114,805,488 ED encounters were recorded including 233,242 ED encounters regarding suicidal attempts. Men accounted for 45.7%. A significantly higher frequency of ED encounters for suicidal acts were found on Sundays in the months of May-June for both sexes and on New Year's Day for all genders and age groups. An increased risk was also noted on July 14th (National Day) and June 22nd (Summer Solstice). A protective effect was noted on the day after Valentine's Day, on Christmas Day and Christmas time (in particular December 24 and 26). CONCLUSION Sundays, June, New Year's Day were at increased risk of suicidal attempts in France requiring a strengthening of prevention.
Collapse
Affiliation(s)
- Michaël Rochoy
- University Lille, Department of General Practice/Family Medicine, 59000 Lille, France; University Lille, CHU Lille, ULR 2694-METRICS: Evaluation des technologies de santé et des pratiques médicales, 59000 Lille, France.
| | - Isabelle Pontais
- Santé publique France, French National Public Health Agency, Data science Division, 94415 Saint-Maurice, France
| | - Céline Caserio-Schönemann
- Santé publique France, French National Public Health Agency, Data science Division, 94415 Saint-Maurice, France
| | - Christine Chan-Chee
- Santé publique France, French National Public Health Agency, Data science Division, 94415 Saint-Maurice, France
| | - Luce Gainet
- University Lille, Department of General Practice/Family Medicine, 59000 Lille, France
| | - Yann Gobert
- University Lille, Department of General Practice/Family Medicine, 59000 Lille, France
| | - Jan Baran
- University Lille, CHU Lille, ULR 2694-METRICS: Evaluation des technologies de santé et des pratiques médicales, 59000 Lille, France
| | - Vincent Dodin
- GHICL, Service de psychiatrie, Saint-Vincent de Paul Hospital, 59000 Lille, France
| | - Luc Defebvre
- University Lille, CHU Lille, Inserm, UMR-S1172 - Lille Neuroscience & Cognition, Movement Disorders Department, 59000 Lille, France
| | - Claire Collins
- Research Department, Irish College of General Practitioners, 4-5 Lincoln Place, Dublin 2, Ireland
| | - Emmanuel Chazard
- University Lille, CHU Lille, ULR 2694-METRICS: Evaluation des technologies de santé et des pratiques médicales, 59000 Lille, France
| | - Christophe Berkhout
- University Lille, Department of General Practice/Family Medicine, 59000 Lille, France; University of Antwerp, Department of primary and interprofessional care, B-2000, Antwerp, Belgium
| | - Pierre Balayé
- University Lille, CHU Lille, ULR 2694-METRICS: Evaluation des technologies de santé et des pratiques médicales, 59000 Lille, France
| |
Collapse
|
4
|
Bruneaux E, Iborra F, Trouche-Sabatier SG, Foucan AS, Gras-Aygon C, Poinas G, Rébillard X, Azria D, Trétarre B. [Bladder tumors in the Hérault department: Results of the Hérault tumor registry registration from1987 to 2019]. Prog Urol 2023; 33:974-982. [PMID: 37648602 DOI: 10.1016/j.purol.2023.08.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2023] [Revised: 07/10/2023] [Accepted: 08/01/2023] [Indexed: 09/01/2023]
Abstract
OBJECTIVES The Hérault Tumor Registry (RTH) is a general registry qualified by the national committee of registries since 1987. The objective of this study is to present the evolution of the epidemiology of bladder cancer (stage≥T1) in the Hérault department based on data collected by the RTH over a period from 1987 to 2019. MATERIAL AND METHODS We analyzed trends in bladder cancer incidence in Hérault between 1987 and 2019 by sex, age, and stage, as well as mortality trends between 1987 and 2017. For the years 2018-2019, which are the last two years validated by the registry, we described relative frequencies, sex ratio, mean and median age at diagnosis, cumulative risk, stages at diagnosis, pathology data, and primary treatments. Observed and net survival data are analyzed for those diagnosed between 01/01/2000 and 12/31/2015 with a point date of 06/30/2018. RESULTS In 2018-2019, bladder cancer was the 7th most common cancer in Hérault (5th in men and 12th in women) with an incidence sex ratio of 3.9 men to one woman. The mean age at diagnosis was 75.3 years for men and 77.8 years for women. The probability of having bladder cancer before the age of 75 years was 1.68% for a man (1/59) and 0.34% for a woman (1/295). Urothelial carcinomas accounted for 90.7% of cancers. Between 1987 and 2019, bladder cancer incidence TSMs (worldwide standardized rates) decreased by 0.8% per year in men and remained stable in women. Mortality TSMs between 1987 and 2017 followed the same trends with a decrease of 2.2% per year in men and stability in women. For the 3304 bladder cancers diagnosed between 01/01/2000 and 12/31/2015, the observed 5-year survival was 38% (34% in women and 38% in men). CONCLUSIONS Bladder cancer incidence and mortality rates have decreased slightly in men but remain stable in women in the Hérault. Registries collect only a limited number of variables for each patient. In 2018 the Hérault Registry Specialized in Onco-Urology (RHESOU) was created, to have comprehensive data. LEVEL OF EVIDENCE: 4
Collapse
Affiliation(s)
- E Bruneaux
- Département d'urologie, centre hospitalier universitaire Lapeyronie, avenue doyen Gaston-Giraud, 34090 Montpellier, France.
| | - F Iborra
- Département d'urologie, centre hospitalier universitaire Lapeyronie, avenue doyen Gaston-Giraud, 34090 Montpellier, France; Registre des tumeurs de l'Hérault, Montpellier, France
| | | | - A S Foucan
- Registre des tumeurs de l'Hérault, Montpellier, France
| | - C Gras-Aygon
- Registre des tumeurs de l'Hérault, Montpellier, France
| | - G Poinas
- Département d'urologie, clinique Beau Soleil, Montpellier, France
| | - X Rébillard
- Département d'urologie, clinique Beau Soleil, Montpellier, France
| | - D Azria
- Institut national de la santé et de la recherche médicale U1194, institut du cancer, université Montpellier, Montpellier, France
| | - B Trétarre
- Registre des tumeurs de l'Hérault, Montpellier, France; CERPOP, université de Toulouse, institut national de la santé et de la recherche médicale UPS, Toulouse, France
| |
Collapse
|
5
|
Ikhlef M, Ailem A. [Epidemiological and clinical features of primary open angle glaucoma in Bejaia: "The Bejaia Eye Study"]. J Fr Ophtalmol 2023; 46:1182-1194. [PMID: 37872068 DOI: 10.1016/j.jfo.2023.05.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2023] [Revised: 05/12/2023] [Accepted: 05/15/2023] [Indexed: 10/25/2023]
Abstract
PURPOSE To determine the prevalence of POAG and its clinical features in a population aged 40years and over in Bejaia. METHODS This was a descriptive, cross-sectional survey for analytical purposes in a representative sample from the municipality of Bejaia. The target population consists of residents of the municipality aged 40 and over who were examined in basic health facilities in the municipality of Bejaia, from May 31, 2015 to July 12, 2016. The visual field, OCT, vertical C/D and intraocular pressure (IOP) criteria were used to define whether or not primary open angle glaucoma was present. RESULTS A total of 1484 people (99 %) participated in the study. The mean age of the study population was 57.97±10.77years, with a median of 56years and sex ratio of 1.07. The prevalence of glaucoma in our study was 5.5 %: POAG 4.6 % (95% CI=3.5-5.7); PACG 0.3 % (95 % CI=0.1, 0.7); secondary glaucoma 0.5 % (95 % CI=0.2-0.7). The prevalence of ocular hypertension was 3.0 % (95% CI=2.2-4.0). The age-adjusted prevalence was 0.8 % between 40 and 49years of age and 6.9% between 60 and 69years of age. The mean age was 66.76±9.31years for men and 67.68±12.10years for women. The mean IOP was 17.53±5.69mm Hg. The mean pachymetry was 518.3±34.3μm in the right eye and 517.4±33.9μm in the left eye. The mean cup/disc ratio was 0.7±0.2 in both eyes. Multivariate analysis of risk factors in our study showed that age and ocular hypertension were significantly associated with the presence of POAG. DISCUSSION The prevalence of POAG is disparate in relation to the age difference, the method of recruitment and the diagnostic criteria: in Bejaia, it is 4.6 %; in Morocco: Marrakech 2.0 %, Fez 6.4 %; in Tunisia: Bardo 2.7 %, Mahdia 2.4 %. The prevalence of POAG increases exponentially with age without significant gender difference. The inclusion of suspect cases influences the prevalence (Beaver Dam, Namil Study). We found that the prevalence of OHT in our study approximates that of the BMES, but it did not show a significant increase with age. The mean CCT in Bejaia (526.35±34.86 microns) and Fez (522.16±41.45 microns) are comparable. The mean vertical C/D ratio in Bejaia was also comparable to data in the literature. A significant difference was observed in the mean median deviation (MD) between subjects with glaucoma and normal subjects. The retinal nerve fiber layer as well as the mean ganglion cell complex thickness in glaucoma subjects was significantly thinner than in healthy subjects. CONCLUSION The prevalence of POAG is high, similar to that of people of African descent, but at older ages and among men. The rate of glaucoma in Bejaia rises significantly with age. Glaucoma is a major ocular health problem and will become increasingly important as the population ages.
Collapse
Affiliation(s)
- M Ikhlef
- Université Abderrahmane MIRA de Bejaia, Bejaia, Algérie.
| | - A Ailem
- Université d'Alger 1, Alger, Algérie
| |
Collapse
|
6
|
Daudon M, Haymann JP, Estrade V, Meria P, Almeras C. 2022 Recommendations of the AFU Lithiasis Committee: Epidemiology, stone analysis and composition. Prog Urol 2023; 33:737-765. [PMID: 37918977 DOI: 10.1016/j.purol.2023.08.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 07/27/2023] [Accepted: 08/01/2023] [Indexed: 11/04/2023]
Abstract
The incidence of urinary lithiasis is rising steadily in industrialized countries, and its prevalence in the general population of France is estimated at 10%. Renal colic accounts for 1-2% of emergency department consultations. At a time when the new LASER stone fragmentation techniques available to urologists will lead to ever finer in situ pulverization of stones, the exact identification of the compounds that form the stone is essential for etiological diagnosis. Constitutional analysis by infrared spectrophotometry or X-ray diffraction is therefore recommended, to be complemented by morphological typing of the calculi. METHODOLOGY: These recommendations have been drawn up using two methods: the Recommendation for Clinical Practice (RPC) method and the ADAPTE method, depending on whether or not the issue was considered in the EAU recommendations (https://uroweb.org/guidelines/urolithiasis) [EAU 2022] and their adaptability to the French context.
Collapse
Affiliation(s)
- M Daudon
- CRISTAL Laboratory, Tenon Hospital, SFBC, Paris, France; Inserm, UMRS 1155 UPMC, Tenon Hospital, Paris, France
| | - J-P Haymann
- Inserm, UMRS 1155 UPMC, Tenon Hospital, Paris, France; Service d'Explorations Fonctionnelles Multidisciplinaires, Tenon Hospital, SP, Paris, France
| | - V Estrade
- Department of Urology, CHU Pellegrin, Bordeaux, France
| | - P Meria
- Service d'Urologie, Hôpital Saint-Louis, AP-HP-Centre Université Paris Cité, Paris, France
| | - C Almeras
- UroSud, clinique La Croix du Sud, Quint-Fonsegrives, France.
| |
Collapse
|
7
|
Ettayeb R, Couanon M, David C, Touze R, Bourges JL, Tuil E, Adam R, Nordmann JP, Bennedjai A. Epidemiological features of ophthalmic emergencies during the COVID-19 lockdown: Impact of the health crisis in a tertiary care center. J Fr Ophtalmol 2023; 46:712-719. [PMID: 37429806 DOI: 10.1016/j.jfo.2023.05.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2023] [Accepted: 05/25/2023] [Indexed: 07/12/2023]
Abstract
PURPOSE The goal of this study is to examine changing patterns of ophthalmic visits in an emergency eye care unit of a tertiary referral center in Paris, France, during the Coronavirus disease-19 (COVID-19) pandemic compared to a control period. MATERIALS AND METHODS This was a single-center, retrospective, observational, epidemiological study. We included all visits in the emergency eye care unit of the Quinze-Vingts National Ophthalmology Center, Paris, France, from March 17, 2020 to April 30, 2020, and a corresponding time period in 2016. We analyzed patients' demographic factors, chief complaints, referral patterns, examination findings, treatment provided, hospitalizations and surgical interventions. RESULTS During the 6weeks of lockdown, 3547 emergency visits were recorded. The control group contained 2108 patients from June 6-19, 2016. There was a decrease of approximately 50% in the number of average daily visitations. The frequency of serious diagnoses (including severe eye inflammation, serious infections, retinal vascular pathologies, surgical emergencies, and neuro-ophthalmology), increased overall during the period (P=0.03). The proportion of low severity pathologies decreased (P<0.001) between the two periods. In addition, an increased amount of ancillary testing was performed (P<0.001). Finally, the rate of hospitalizations was significantly lower during the lockdown period (P<0.001). CONCLUSION A significant reduction in total ophthalmic presentations in the emergency eye care unit was observed during the lockdown period. However, the proportion of emergencies requiring specialized treatments (surgical, infectious, inflammatory and neuro-ophthalmological pathologies) increased.
Collapse
Affiliation(s)
- R Ettayeb
- Service 2, centre hospitalier national des Quinze-Vingts, 28, rue de Charenton, 75012 Paris, France.
| | - M Couanon
- Service 2, centre hospitalier national des Quinze-Vingts, 28, rue de Charenton, 75012 Paris, France
| | - C David
- Service 5, centre hospitalier national des Quinze-Vingts, 75012 Paris, France
| | - R Touze
- Hôpital Necker, 149, rue de Sèvres, 75015 Paris, France
| | | | - E Tuil
- Service des urgences, centre hospitalier national des Quinze-Vingts, 75012 Paris, France
| | - R Adam
- Service 2, centre hospitalier national des Quinze-Vingts, 28, rue de Charenton, 75012 Paris, France
| | - J-P Nordmann
- Service 2, centre hospitalier national des Quinze-Vingts, 28, rue de Charenton, 75012 Paris, France
| | - A Bennedjai
- Service 2, centre hospitalier national des Quinze-Vingts, 28, rue de Charenton, 75012 Paris, France
| |
Collapse
|
8
|
Boukheris H, Brakni L, Fihri Boubezari R, Bettayeb A, Bachir Bouaidjra N, Bensetti Houari A, Mohamed Brahim F, Simerabet A, Achour Z, Attar S, Saim H, Berber N. [Evaluation of thyroid cancer data completeness and quality at a population-based cancer registry, Algeria]. Bull Cancer 2023; 110:873-882. [PMID: 36949001 DOI: 10.1016/j.bulcan.2023.02.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2022] [Revised: 02/14/2023] [Accepted: 02/25/2023] [Indexed: 03/24/2023]
Abstract
BACKGROUND Over the last three decades the incidence of thyroid cancer (TC) has increased in many regions of the world, however little is known about TC incidence and trends in Algeria. MATERIAL AND METHODS Using data from the Oran cancer registry (OCR) we assessed TC incidence and trends in Oran for the period 1996-2013 with the historical data method. The incidence curves were unstable and did not show any clear trend. Therefore, we actively collected data on TC for the period 1996-2013 using the multisource approach and the independent case ascertainment method. RESULTS Analysis of actively collected and validated data showed a significant increase in the incidence of TC. We compared the two databases to identify differences. There were 558 TC cases during the period 1996-2013 in the OCR, while our active data collection enabled us to find 1,391 TC cases during the same period. The completeness rate in the OCR was 40.1%. These differences were due to our approach that consisted in the inclusion of a greater number of health facilities and laboratories (44 versus 23 in the OCR), and the active data collection in the nuclear medicine facility of the University Hospital of Tlemcen that we undertook. CONCLUSIONS The application of the recommendations of the International Agency for Research on Cancer (IARC) to enhance data completeness and quality, and an active collection of TC data in the nuclear medicine facility of the University Hospital of Tlemcen should make the OCR an essential tool for decision-making in public health and for directing health policy towards health priorities.
Collapse
Affiliation(s)
- Houda Boukheris
- Université Abderrahmane Mira de Bejaia, Faculté de médecine; CHU de Bejaia, service d'épidémiologie et médecine préventive.
| | - Lila Brakni
- Université d'Alger, Faculté de médecine; Hôpital Central de l'Armée, service d'endocrinologie et maladies métaboliques
| | - Reda Fihri Boubezari
- Université Abderrahmane Mira de Bejaia, Faculté de médecine; CHU de Bejaia, service des urgences
| | | | | | - Amina Bensetti Houari
- Université d'Oran, Faculté de médecine; CHU d'Oran, service de chirurgie générale adulte
| | - Farouk Mohamed Brahim
- Université d'Oran, Faculté de médecine; CHU d'Oran, service de chirurgie générale adulte
| | - Azeddine Simerabet
- Université d'Oran, Faculté de médecine; CHU d'Oran, service de chirurgie thoracique
| | - Zineb Achour
- CHU de Tlemcen, service d'épidémiologie et médecine préventive
| | - Sara Attar
- CHU de Tlemcen, service d'épidémiologie et médecine préventive
| | - Hafida Saim
- CHU de Tlemcen, service d'épidémiologie et médecine préventive
| | - Necib Berber
- CHU De Tlemcen, service de médecine nucléaire; Université de Tlemcen, Faculté de Médecine, Tlemcen, Algérie
| |
Collapse
|
9
|
Garcin B, Roze E, Daubigney A, Carle-Toulemonde G, Degos B, Hingray C. [Diagnostic criteria, epidemiology and assessment of patients with functional neurological disorders]. Encephale 2023:S0013-7006(23)00083-0. [PMID: 37400337 DOI: 10.1016/j.encep.2023.06.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/22/2022] [Accepted: 06/05/2023] [Indexed: 07/05/2023]
Abstract
Functional neurological disorders (FND) are symptoms that can affect a variety of functions including motor, sensory and cognitive. These symptoms are genuinely experienced by the patient and are related to a functional disorder rather than a structural one. There is little epidemiological data on these disorders, but their frequency is well established in clinical practice, it is the second most frequent reason for consultation in Neurology. Despite of the frequency of the disorder, general practitioners and specialists are insufficiently trained in the disease, and patients often suffer from stigmatization and/or unnecessary investigations. It is therefore important to be aware of the diagnostic approach to FND, which mostly relies on positive clinical signs. Psychiatric evaluation can help with the characterization of predisposing, precipitating and perpetuating factors of the symptoms (according to the 3P biopsychosocial model related to FND), and guide their management. Finally, diagnosis explanation is a crucial step in the management of the disease, which can in itself have a therapeutic effect, and allow the patient to adhere to the treatments.
Collapse
Affiliation(s)
- Béatrice Garcin
- Service de neurologie, hôpital Avicenne, hôpitaux universitaires de Paris - Seine-Saint-Denis, Sorbonne Paris Nord, Assistance publique-Hôpitaux de Paris, 93000 Bobigny, France.
| | - Emmanuel Roze
- Inserm, CNRS, Institut du cerveau, Hôpital Salpêtrière, DMU Neurosciences, Sorbonne université, Assistance publique-Hôpitaux de Paris, 75013 Paris, France
| | - Antoine Daubigney
- Équipe mobile de neuropsychiatrie, pôle de neurosciences cliniques, CHU de Bordeaux et pôle de psychiatrie générale et universitaire du centre hospitalier Charles-Perrens, 33076 Bordeaux, France
| | - Guilhem Carle-Toulemonde
- Cabinet de psychosomatique et stimulation magnétique transcrânienne, clinique Saint-Exupery, 31400 Toulouse, France
| | - Bertrand Degos
- Service de neurologie, hôpital Avicenne, hôpitaux universitaires de Paris - Seine-Saint-Denis, Sorbonne Paris Nord, Assistance publique-Hôpitaux de Paris, 93000 Bobigny, France
| | | |
Collapse
|
10
|
Arlet JB. [Sickle cell disease imposes itself to French internists in the 21st century]. Rev Med Interne 2023; 44:325-327. [PMID: 37246036 DOI: 10.1016/j.revmed.2023.05.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2023] [Accepted: 05/15/2023] [Indexed: 05/30/2023]
Affiliation(s)
- J-B Arlet
- Université Paris-Cité, Paris, France; Service de médecine interne, Centre national de référence drépanocytose, thalassémie, autres maladies rares des globules rouges et de l'érythropoïèse, hôpital européen Georges-Pompidou, AP-HP, 20, rue Leblanc, 75015 Paris cedex 15, France.
| |
Collapse
|
11
|
Spinney L. [Deadliest flu]. C R Biol 2023; 346:35-38. [PMID: 37254780 DOI: 10.5802/crbiol.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2023] [Accepted: 02/21/2023] [Indexed: 06/01/2023]
Abstract
Many questions remain unanswered regarding the so-called "Spanish" influenza pandemic of 1918. This article addresses three of them and describes the state of knowledge for each of them: Where did the pandemic start? How many people died? And why was it so deadly?
Collapse
|
12
|
Bruzard H, Soler P, Varenne F, Sentis V, Fournié P, Soler V. [Influence of the COVID-19 pandemia on the ophthalmologic emergency department in the Toulouse University Hospital during the first lockdown from March the 17th to May the 10th of 2020]. J Fr Ophtalmol 2023; 46:2-10. [PMID: 36503813 PMCID: PMC9701637 DOI: 10.1016/j.jfo.2022.07.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2022] [Revised: 07/25/2022] [Accepted: 07/27/2022] [Indexed: 11/29/2022]
Abstract
INTRODUCTION We conducted this study to assess the impact of the COVID-19 pandemic and the lockdown in France from March 17, 2020 to May 10, 2020, on the ophthalmic emergency department at Toulouse University Hospital, compared to the period from March 2 to March 16, 2020. MATERIALS AND METHODS This was a retrospective observational study, conducted in the ophthalmic emergency department of Toulouse University Hospital. We included the patients presenting to the emergency department from March 2 to May 10, 2020. We recorded age, sex, day of visit, time until care was received, past ocular history, outpatient or inpatient status, final diagnosis and its severity, outpatient or inpatient disposition, and medical or surgical treatment after the emergency department visit. RESULTS We found a substantial decrease in the number of patients per day, mostly during the first month of the lockdown: 44 patients per day before the lockdown compared to 23 patients per day during the first month, followed by 38 patients per day for the second month of lockdown; more patients visiting promptly; and elderly patients represented a higher proportion of patients. CONCLUSION The first lockdown in France due to the COVID-19 pandemic had an impact on the Toulouse ophthalmic emergency department, especially concerning the number of patients per day; this study helps to assess individual behavior in this context of a public health crisis.
Collapse
Affiliation(s)
- H. Bruzard
- Ophthalmology Department, Pierre-Paul-Riquet Hospital, Toulouse University Hospital, Toulouse, France,Auteur correspondant. 5, rue Jacob-Insel, Résidence Emeraude, Bâtiment D, Appartement 139, 31200 Toulouse, France
| | - P. Soler
- EFS Occitanie centre de soins, 1, avenue Irène-Joliot-Curie, Toulouse, France
| | - F. Varenne
- Ophthalmology Department, Pierre-Paul-Riquet Hospital, Toulouse University Hospital, Toulouse, France
| | - V. Sentis
- Ophthalmology Department, Pierre-Paul-Riquet Hospital, Toulouse University Hospital, Toulouse, France
| | - P. Fournié
- Ophthalmology Department, Pierre-Paul-Riquet Hospital, Toulouse University Hospital, Toulouse, France,Université Toulouse III, 31000 Toulouse, France
| | - V. Soler
- Ophthalmology Department, Pierre-Paul-Riquet Hospital, Toulouse University Hospital, Toulouse, France,Université Toulouse III, 31000 Toulouse, France,SV3 team, CERCO, UMR5549, Toulouse, France
| |
Collapse
|
13
|
Petit V, Lenain R, Debillon F, Hazzan M, Provot F. [Association between controlled circulatory death donor waitlisting and waiting time before kidney transplantation in a French center]. Nephrol Ther 2022; 18:604-610. [PMID: 36357263 DOI: 10.1016/j.nephro.2022.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2022] [Revised: 08/25/2022] [Accepted: 09/20/2022] [Indexed: 11/09/2022]
Abstract
INTRODUCTION Transplantation from controlled donation after circulatory determination of death (cDCD) is a new practice in France. An additional specific consent is required for registration on the cDCD waiting list. The aim of this study is to evaluate the impact of cDCD acceptance on the waiting time for the registered patients on the transplant list. METHODS Patients registered on the kidney transplant waiting list for a Death Brain Donor (DBD) kidney transplant between 2018 and 2019 in our center were included. Patients who were candidates for a second kidney transplant or who had already received an organ transplant were not included. The cDCD waiting list registration was authorized by a signed consent of the patient on the day of DBD registration. The primary endpoint was time to renal transplantation. RESULTS Of the 315 patients eligible for a cDCD graft at transplant list registration, 152 were registered on the cDCD waiting list. Time to transplantation for these patients was multiplied by 1.42 (95%CI 1.07-1.87) compared with patients not registered for a cDCD graft. The time to transplantation was 2.59 months (95%CI 0.49-4.69) shorter for a 2-year follow-up for cDCD-listed patients. This represents one additional transplant at 6 months for every seven registered patients. CONCLUSION cDCD waiting list registration reduced the time to kidney transplantation in France.
Collapse
Affiliation(s)
- Vivien Petit
- Service de néphrologie, CHU de Lille, Lille, France; Service de néphrologie, centre hospitalier de Dunkerque, 59240 Dunkerque, France.
| | - Remi Lenain
- Service de néphrologie, CHU de Lille, Lille, France; Inserm UMR 1246 - SPHERE, université de Nantes, université de Tours, Nantes, France
| | | | - Marc Hazzan
- Service de néphrologie, CHU de Lille, Lille, France
| | | |
Collapse
|
14
|
Bertinchamp R, Terriou L. Maladies de Castleman : épidémiologie, classification et critères diagnostiques. Rev Med Interne 2022; 43:10S4-10S9. [PMID: 36657941 DOI: 10.1016/s0248-8663(23)00019-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Castleman disease is a group of rare disorders characterized by lymph node enlargement, specific microscopic changes to the lymph nodes, and a broad range of symptoms and laboratory findings. The two main subtypes are unicentric Castleman disease (UCD) and multicentric Castleman disease (MCD). The multicentric subtype can be further classified into two categories: HHV-8 positive multicentric Castleman disease and idiopathic multicentric Castleman disease (iMCD). In the United States (US), the annual incidence of Castleman disease (CD) has been estimated to range from 6500 to 7700 in a 2014 study. Approximately 75 percent were estimated to be unicentric CD and the remaining 25 percent were estimated to be split between HHV-8-associated MCD or HHV-8-negative/idiopathic MCD. Diagnostic criteria for iMCD have been established by an international working group of pediatric and adult pathology and clinical experts. The proposed consensus criteria require characteristic histopathologic findings on lymph node biopsy, enlargement of multiple lymph node regions, the presence of multiple clinical and laboratory abnormalities, and the exclusion of infectious, malignant, and autoimmune disorders that can mimic iMCD. © 2022 Published by Elsevier Masson SAS on behalf of Société nationale française de médecine interne (SNFMI).
Collapse
Affiliation(s)
- R Bertinchamp
- Service de médecine interne et immunologie clinique, CHU Antoine-Béclère, Clamart, France.
| | - L Terriou
- Service de médecine interne et immunologie clinique, Centre de référence des maladies auto-immunes systémiques rares du nord et nord-ouest de France (CeRAINO), CHU de Lille, Lille, France
| |
Collapse
|
15
|
Bajeot AS, Roumiguié M, Rébillard X, Descotes JL, Duguet C, Lebret T, Fournier G, Corbel L, Gamé X, Soulié M. [De novo or secondary metastatic prostate cancer management in France: Observational study from "sentinel multidisciplinary meeting" of the French Association of Urology]. Prog Urol 2022; 32:691-701. [PMID: 35787978 DOI: 10.1016/j.purol.2022.04.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2021] [Revised: 04/05/2022] [Accepted: 04/28/2022] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Metastatic prostate cancer (mPCa) is an heterogeneous disease. Metachronous mPCa (MM) seems to have a better prognosis than synchronous mPCa (SM). However, it is difficult to analyze their specificities from national registries. Data from the so-called "sentinel multidisciplinary meeting" (SMDM) would represent a "real life" data collection. The objective of this national pilot study was to evaluate the concept of SMDM through the description and comparison of the diagnosis, management and follow-up of patients with synchronous or metachronous mPCa in 2018. METHODS A survey covering clinical, biological, radiological data as well as treatment initiated and follow-up at 3 and 6 months was sent to the SMDM. All patients diagnosed with metastatic disease (SM or MM) between 01/01/2018 and 11/30/2018 were included. RESULTS In total, 780 patients from 39 centers were included, 408 SM and 372 MM. SM were more symptomatic and had a higher metastatic burden than MM. PET were mostly performed in MM without a prior standard staging. SM patients received more chemotherapy than MM patients whereas new generation androgen deprivation therapy was mostly given to MM patients. At 6 months, there were no more significant difference in clinical presentation between the two groups. CONCLUSION Specificities of SM and MM patients in terms of clinical presentation, metastatic burden and management were described, validating the concept of SMDM as a source of reliable informations. LEVEL OF EVIDENCE: 4
Collapse
Affiliation(s)
- A-S Bajeot
- Département d'urologie-andrologie-transplantation rénale, institut universitaire du Cancer, université Paul Sabatier, CHU de Toulouse, Toulouse, France.
| | - M Roumiguié
- Département d'urologie-andrologie-transplantation rénale, institut universitaire du Cancer, université Paul Sabatier, CHU de Toulouse, Toulouse, France
| | | | - J-L Descotes
- Service d'urologie, CHU de Grenoble, Grenoble, France
| | - C Duguet
- Département d'urologie-andrologie-transplantation rénale, institut universitaire du Cancer, université Paul Sabatier, CHU de Toulouse, Toulouse, France
| | - T Lebret
- Service d'urologie, hôpital Foch, Suresnes, France
| | - G Fournier
- Service d'urologie, CHU de Brest, Brest, France
| | - L Corbel
- Service d'urologie, hôpital privé des côtes d'Armor, Plérin, France
| | - X Gamé
- Département d'urologie-andrologie-transplantation rénale, institut universitaire du Cancer, université Paul Sabatier, CHU de Toulouse, Toulouse, France
| | - M Soulié
- Département d'urologie-andrologie-transplantation rénale, institut universitaire du Cancer, université Paul Sabatier, CHU de Toulouse, Toulouse, France
| | | |
Collapse
|
16
|
Abstract
HER2, a human epidermal growth factor, being activated by amplification, is a negative prognostic factor in breast cancer. HER2 is the target of anti-HER2 antibodies (Trastuzumab, Pertuzumab…). For more than 10 years, breast cancers have been classified into HER2 positive and HER2 negative. However, the advent of new cytotoxic drugs combined with anti-HER2 antibodies, such as TDM1 or trastuzumab déruxtécan, have shown very promising therapeutic activity in patients with low HER2 expression breast cancer. These new therapeutic perspectives encourage a better identification of low HER2 tumours in order to identify patients who could benefit from them. Thus, the classification of breast tumours evolves to individualize HER2-negative tumours (score 0), HER2-positive tumours (score 3+ and 2+ amplified) and HER2-low tumours (scores 1+ and 2+ not-amplified). HER2-low tumours are common and represent more than half of all breast cancers. To identify these HER2-low tumours, pathology laboratories should not change their usual technique calibrated according to ASCO/CAP and GEFPICS recommendations. Until more clinical data about response to these new treatment strategies are available, GEFPICS does not require pathologists to identify this HER2-low category. Nevertheless, this designation will allow clinicians to identify patients whose tumours fall into this category in the very short term and offer them new treatment options.
Collapse
Affiliation(s)
- Élise Deluche
- Département d'oncologie médicale, CHU de Limoges, 2 avenue Martin-Luther-King, 87000 Limoges, France.
| | - Anne Vincent-Salomon
- Institut Curie, département de médecine diagnostique et théranostique, service de pathologie, université Paris-Sciences et Lettres, Unité INSERM U934, 26 rue d'Ulm, 75005 Paris, France
| |
Collapse
|
17
|
Zaghbib S, Chakroun M, Saadi A, Boussaffa H, Bouzouita A, Derouiche A, Ben Slama MR, Ayed H, Chebil M. Vesico-vaginal fistula in Tunisia: Epidemiology and risk factors of treatment failure. Prog Urol 2021; 31:1175-81. [PMID: 34656449 DOI: 10.1016/j.purol.2021.09.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2021] [Revised: 05/17/2021] [Accepted: 09/22/2021] [Indexed: 11/21/2022]
Abstract
INTRODUCTION Vesico-vaginal fistula (VVF) is a global healthcare problem that has a high prevalence in developing countries. The aim of this work is to study the epidemiological, clinical and therapeutic characteristics of VVF post-obstetric and gynecologic procedures in order to identify the predictive factors of surgical treatment failure. METHODS Data were collected from 132 VVF patients in our institution between 1985 and 2017. VVF was classified according to Zmerli's classification. Patients underwent surgical treatment and were evaluated after a follow-up period of 6 months. Successful treatment was defined as the absence of urine leakage whereas recurrence was defined as the presence of urine leakage immediately after the surgery or after a period of dryness with a confirmed VVF. Risk factors of surgical treatment failure were identified. RESULTS The average age of patients was 44 years. The patients were multiparous in 62% of cases. VVF was consecutive to hysterectomy in 62.1% of cases, and after childbirth in 34%. VVF was retro-trigonal in 99 cases (75%) and trigonal in 33 cases (25%). The average size of the fistula was 1cm (0.3-2cm). VVF repair was performed by vaginal approach in 68% of cases and abdominal approach in 32% of cases. Treatment failure was noted in 36 patients (27%). Predictive factors of treatment failure were: vaginal fibrosis (P<0.001); trigonal location of the fistula (P<0.001); large diameter of the VVF>1cm (P<0.001); and complex and complicated fistulas (P=0.02). CONCLUSION Although Tunisia is a developing country, the main cause of VVF was not obstetrical. Treatment failure, noted in almost one third of cases, was, in our series, correlated with the quality of the vaginal tissue, the size and the location of the fistula, and its complexity. LEVEL OF PROOF 4.
Collapse
|
18
|
Bukasa Kakamba J, Sabbah N, Bayauli P, Massicard M, Bidingija J, Nkodila A, Mbunga B, Ditu S, Beckers A, Potorac I. Thyroid cancer in the Democratic Republic of the Congo: Frequency and risk factors. Ann Endocrinol (Paris) 2021; 82:606-612. [PMID: 34624256 DOI: 10.1016/j.ando.2021.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/11/2021] [Accepted: 09/15/2021] [Indexed: 10/20/2022]
Abstract
BACKGROUND The prevalence of thyroid cancer is increasing steadily in most countries, partly due to better, earlier diagnosis. However, there is little data for developing countries, where the technical platform is often very limited, especially in Africa. OBJECTIVES To assess the frequency of thyroid cancer in the Democratic Republic of the Congo (DRC) and to analyze the epidemiological, clinical, and ultrasound risk factors. MATERIAL AND METHODS This is a multicenter cross-sectional study of 594 patients operated on for a thyroid mass from 2005 to 2019, in 35 centers in the DRC and for whom histopathological analyses were performed. RESULTS The frequency of thyroid cancers in our cohort was 20%, mostly in patients over the age of 40 (62% of patients). These cancers were mainly diagnosed at the clinical stage, due to the presence of palpable masses. Papillary cancer was the most common (67.2% of patients), followed by follicular cancer (28% of cases). We found a high prevalence of anaplastic cancer (7.6%). These frequencies are probably the consequence of the fact that histopathological analyses are not systematically performed in the DRC, but mostly on tissues that the thyroid surgeons suspect to be malignant. Age ≥60 years, the presence of adenopathies upon palpation or on ultrasound, the solid nature and hypoechogenicity of nodules, the presence of macronodules and calcifications were the factors independently associated with the diagnosis of cancer in the study population. CONCLUSIONS In this first study performed in the DRC, we have found that thyroid cancer is common. It is mainly detected at clinical stages, with patients over the age of 40 years and women being the most affected. The histopathology distribution differs from that in developed countries, with a lower prevalence of papillary cancer and a higher prevalence of the anaplastic type. In developing countries, it appears necessary to introduce the use of more precise diagnostic tools for thyroid cancer and also, to reinforce the improvement of known, controllable risk factors such as iodine deficiency.
Collapse
Affiliation(s)
- John Bukasa Kakamba
- Department of Endocrinology, Metabolism and Nuclear Medicine, Kinshasa University Clinics, Democratic Republic of the Congo; Department of Endocrinology, Metabolism and Nutrition, André Rosemon Hospital Center, 97306 Cayenne, French Guiana; Department of Endocrinology, CHU de Liège, Université de Liège, Liège, Belgium.
| | - Nadia Sabbah
- Department of Endocrinology, Metabolism and Nutrition, André Rosemon Hospital Center, 97306 Cayenne, French Guiana; Clinical Research Center (CIC), French National Institute of Health and Medical Research (INSERM) 1424, Antilles French Guiana, French Guiana
| | - Pascal Bayauli
- Department of Endocrinology, Metabolism and Nuclear Medicine, Kinshasa University Clinics, Democratic Republic of the Congo
| | - Michael Massicard
- Department of Endocrinology, Metabolism and Nutrition, André Rosemon Hospital Center, 97306 Cayenne, French Guiana
| | - Joseph Bidingija
- Department of Endocrinology, Metabolism and Nuclear Medicine, Kinshasa University Clinics, Democratic Republic of the Congo
| | - Aliocha Nkodila
- Department of Family Medicine, Protestant University of Congo, Democratic Republic of the Congo
| | - Branly Mbunga
- Public School of Health, University of Kinshasa, Democratic Republic of the Congo
| | - Symporien Ditu
- Department of Endocrinology, Metabolism and Nuclear Medicine, Kinshasa University Clinics, Democratic Republic of the Congo
| | - Albert Beckers
- Department of Endocrinology, CHU de Liège, Université de Liège, Liège, Belgium
| | - Iulia Potorac
- Department of Endocrinology, CHU de Liège, Université de Liège, Liège, Belgium
| |
Collapse
|
19
|
Kienlen A, Mazières J, André M, Chirpaz E, Deneche I, Huchot E. [Survival and epidemiological characteristics of women with lung cancer in Reunion]. Rev Mal Respir 2021; 38:882-93. [PMID: 34565642 DOI: 10.1016/j.rmr.2021.06.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2021] [Accepted: 06/17/2021] [Indexed: 11/20/2022]
Abstract
Lung cancer is a common disease throughout the world, representing the main cause of death from cancer. Its incidence in the female population is increasing. In metropolitan France and Reunion Island, the main risk factor remains tobacco smoking. However, environmental, genetic and hormonal factors appear to play a role in bronchial oncogenesis and the survival of affected women is better than that of men. We studied retrospectively the survival and characteristics of a cohort in Reunion Island, diagnosed with lung cancer between January 2017 and December 2018. In total, 501 patients were included over the period including 166 women. The median overall survival was 23 months in women against 11 months in men (P<0.0005). Male sex has been identified as a poor prognostic factor for overall survival (HR=1.338; 95% CI=1.007-1.778) regardless of disease stage. Women smoked less often than men 85.4% of them had adenocarcinoma, with more EGFR mutations than men, and their environmental exposures were lower. The female population of Reunion Island in our study had better overall survival than the men. Smoking status, environmental exposures, histological and molecular characteristics varied by sex.
Collapse
|
20
|
Asgarali E, Gayon J, Viallet N, Vacher-Coponat H. [Kidney biopsy in Reunion Island between 2015 and 2017, an epidemiological study]. Nephrol Ther 2021; 17:512-519. [PMID: 34548266 DOI: 10.1016/j.nephro.2021.06.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2020] [Revised: 06/22/2021] [Accepted: 06/27/2021] [Indexed: 12/01/2022]
Abstract
INTRODUCTION Reunion Island's population is characterized by a multiethnic origin, which makes it impossible to transpose epidemiological data of Metropolitan France. Only REIN Registry provides a macroscopic view of kidney disease, limited to the causes of end stage renal disease. METHODS This is a regional retrospective study whose main objective is to describe renal pathologies in Reunion Island's adults over a period of 3 years. Kidney transplants are excluded. RESULTS Between 2015 and 2017, 338 native adult kidney biopsies performed on the island are collected. The annual biopsy rate is 132/million/year with preponderance in the northern part of the island due to a higher density of nephrologists. Nephrotic syndrome is the first indication with 30% of cases. The four main results are represented by IgA nephropathy (16%), diabetic nephropathy (12.4%), lupus nephropathy (11.2%) and isolated vascular nephropathy (11%). Incidence of glomerulopathies is similar to the worldwide incidence, nevertheless a preponderant place of diabetic nephropathy is found. On the biopsies performed, incidence of complications is evaluated at 7.5%, with no difference between the detection technique used. CONCLUSION This is the first study illustrating main renal pathologies in Reunion Island. Diabetes' frequency in general population is a major confounding factor in diagnosis and management of kidney diseases on the island.
Collapse
Affiliation(s)
- Ehshan Asgarali
- Service de néphrologie, CHU Félix-Guyon , allée des Topazes, 97400 Saint-Denis-La Réunion, France.
| | - Julien Gayon
- Service de néphrologie, CHU Félix-Guyon , allée des Topazes, 97400 Saint-Denis-La Réunion, France
| | - Nicolas Viallet
- Service de néphrologie, CHU Félix-Guyon , allée des Topazes, 97400 Saint-Denis-La Réunion, France
| | - Henri Vacher-Coponat
- Service de néphrologie, CHU Félix-Guyon , allée des Topazes, 97400 Saint-Denis-La Réunion, France; UFR Santé, Saint-Pierre, 97410 La-Réunion, France
| |
Collapse
|
21
|
Cadelis G, Jelli B. [Latent tuberculosis infection (LTBI): What happens at 5 years of the 155 LTBI recent contacts of tuberculosis with positive microscopic examination?]. Rev Mal Respir 2021; 38:816-828. [PMID: 34454815 DOI: 10.1016/j.rmr.2021.05.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Accepted: 05/13/2021] [Indexed: 10/20/2022]
Abstract
INTRODUCTION Contacts of individuals with tuberculosis are at risk of latent infection (LTBI), which can progress to active tuberculosis. The aim of the study was to determine the incidence of tuberculosis in contacts and its risk factors in subjects with LTBI. METHODOLOGY This retrospective study from the tuberculosis control centre in Guadeloupe identified smear-positive tuberculosis cases and their contacts. We estimated the incidence of tuberculosis at 5 years using the Kaplan Meier method and identified risk factors for tuberculosis occurrence among contacts by a Cox model. RESULTS We analysed 292 contacts of 73 individuals with smear-positive tuberculosis between 2008 and 2015. Of these, 155 contacts had LTBI and 8 developed tuberculosis. The risk of developing tuberculosis was 11.5% (CI : 4.3%-23.4%) for untreated subjects and 1.9% (CI: 0.23%-6.8) for treated subjects. Risk factors identified for tuberculosis were: bacillary density of the index case (HR: 9.10, CI: 1.7-48.4), previous BCG (HR: 0.06, CI: 0.01-0.34), and treatment of LTBI (HR: 0.08, CI: 0.01-0.49). CONCLUSIONS This study confirms the relevance of treating LTBI in the context of recent contagion but also the benefit of a BCG vaccination.
Collapse
Affiliation(s)
- G Cadelis
- Service de pneumologie, CHU de Pointe-à-Pitre, Guadeloupe; Centre de lutte antituberculeux de la Guadeloupe, CHU de Pointe-à-Pitre, Guadeloupe.
| | - B Jelli
- Service de pneumologie, CHU de Pointe-à-Pitre, Guadeloupe
| |
Collapse
|
22
|
Jeanjean M, Lees J, Allen BL, Cohen AK. Interdisciplinary community-based participatory health research across the industrial region of the Étang de Berre : The EPSEAL Fos Crau study. Rev Epidemiol Sante Publique 2021; 69:297-305. [PMID: 34256985 DOI: 10.1016/j.respe.2021.04.141] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2020] [Revised: 02/23/2021] [Accepted: 04/17/2021] [Indexed: 11/16/2022] Open
Abstract
BACKGROUND We conducted a community-based participatory environmental health study in three towns: two in the heart of Marseille's industrial zone (Fos-sur-Mer and Port-Saint-Louis-du-Rhône), and one on the periphery located about 30 km away (Saint-Martin-de-Crau). METHODS We first conducted a cross-sectional survey of a random sample of residents in each of the three towns. We asked study participants to self-report a wide variety of health issues (Port-Saint-Louis: n = 272, Fos-sur-Mer: n = 543, Saint-Martin-de-Crau: n = 439). We then conducted focus groups with residents and other stakeholders to share preliminary data in order to propose areas of reflection and collaboratively produce contextually-situated knowledge of their health and environment. We directly standardized the prevalences (by age and gender) to the French metropolitan population to make our results more comparable. RESULTS Study participants who lived closer to the core industrial zone (residents of Fos-sur-Mer and Port-Saint-Louis-du-Rhone) had higher prevalences of eye irritation, nose and throat problems, chronic skin problems and headaches than people who lived further away (residents of Saint-Martin-de-Crau). Residents also offered diverse qualitative insights about their environment and health experiences. DISCUSSION We observed elevated prevalences of diseases that affected residents across the industrial zone (Fos-sur-Mer and Port-Saint-Louis-du-Rhône) compared to those living outside (Saint-Martin-de-Crau), and qualitative evidence of how residents made sense of their health experiences strengthening an understanding of their own empirical observations which helps to produce knowledge about health in an industrial context. The results of the workshops show an important benefit from the co-production of local knowledge. CONCLUSION We encourage future researchers to do in-depth, community-based research to comprehensively describe the health of residents in other heavily polluted zones, product local knowledge and to help identify policy solutions, engender trust among the local people, and identify opportunities for intervention.
Collapse
Affiliation(s)
- Maxime Jeanjean
- Centre Norbert Elias (UMR 85 62), Laboratoire de sciences sociales appliquées, Marseille, France and Institut écocitoyen, Fos-sur-Mer, France.
| | - Johanna Lees
- Centre Norbert Elias (UMR 85 62), Laboratoire de sciences sociales appliquées, Marseille, France
| | - Barbara L Allen
- Department of Science, Technology and Society, Virginia Tech University-National Capital Region, Falls Church, VA, USA
| | - Alison K Cohen
- Department of Epidemiology & Biostatistics, School of Medicine, University of California San Francisco, San Francisco, CA, 94158, USA
| |
Collapse
|
23
|
Kajimina Katumbayi JC, Muyulu NP, Zakayi PK, Lebwaze Massamba B, Sitwaminya RK, Beya Kabongo F, Kisile Mikuwo O, Baleka AM, Kabongo Mpolesha JM, Nicaise M, Chirimwami RB. [Epidemiologic and histopathologic characteristics of 1280 uterine cervical cancers in Kinshasa]. ACTA ACUST UNITED AC 2021; 50:53-61. [PMID: 34242824 DOI: 10.1016/j.gofs.2021.07.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2021] [Indexed: 11/16/2022]
Abstract
OBJECTIVE Due to the lack of both cancer registry and large scale cervical screening in most african countries, only theoretical studies are available. The objective of our work was to provide epidemiological and histopathological characteristics of cervical cancer based on concrete observations. METHODS This study was carried out on all cancers (n=5801) collected in the last 10 years from 5 pathology laboratories of Kinshasa; the histologic slides of the cervical cancers (n=1280) were reviewed by at least two pathologists and classified according to the 2014 OMS classification. RESULTS The cervical cancers accounted for 22% of all cancers and 40,4% of breast and gynecological cancers. The cervical cancer was the most common among women aged 49-58. Squamous cell carcinomas were the most observed type (73,2%) followed by adenocarcinomas (18,4%) and adenosquamous carcinomas (8,4%). Keratinized (47,2%) and non keratinized squamous carcinoma (20,8%) were the most frequent subtypes among squamous carcinomas and the usual adenocarcinoma among adenocarcinomas (9,6%). In the mucinous adenocarcinoma subtype, only the signet ring cells (1,3%) variant was found. Among cervical cancers, 69% were grade I, 20% grade II and 11% grade III. CONCLUSION Our study provides a concrete database of epidemiological and histopathological cervical cancer particularities in Kinshasa, useful to initiate a cancer register, as well as cervical screening and HPV vaccine campaigns.
Collapse
Affiliation(s)
- J-C Kajimina Katumbayi
- Département d'anatomie pathologique, faculté de médecine, université de Kinshasa, BP834, Kinshasa XI, République démocratique du Congo.
| | - N P Muyulu
- Département d'anatomie pathologique, faculté de médecine, université de Kinshasa, BP834, Kinshasa XI, République démocratique du Congo
| | - P K Zakayi
- Département des sciences de base, faculté de médecine, université de Kinshasa, BP834, Kinshasa XI, République Démocratique du Congo
| | - B Lebwaze Massamba
- Département d'anatomie pathologique, faculté de médecine, université de Kinshasa, BP834, Kinshasa XI, République démocratique du Congo
| | - R K Sitwaminya
- Département d'anatomie pathologique, faculté de médecine, université de Kinshasa, BP834, Kinshasa XI, République démocratique du Congo
| | - F Beya Kabongo
- Département d'anatomie pathologique, faculté de médecine, université de Kinshasa, BP834, Kinshasa XI, République démocratique du Congo
| | - O Kisile Mikuwo
- Département d'anatomie pathologique, faculté de médecine, université de Kinshasa, BP834, Kinshasa XI, République démocratique du Congo
| | - A M Baleka
- Département de gyneco-obstétrique, faculté de médecine, université de Kinshasa, BP834, Kinshasa XI, République Démocratique du Congo
| | - J-M Kabongo Mpolesha
- Département d'anatomie pathologique, faculté de médecine, université de Kinshasa, BP834, Kinshasa XI, République démocratique du Congo
| | - M Nicaise
- Faculté de médecine et médecine dentaire, SSS, IREC, pôle morphologie, université Catholique de Louvain, avenue Mounier, 52/B1, 5204, Belgique
| | - R B Chirimwami
- Département d'anatomie pathologique, faculté de médecine, université de Kinshasa, BP834, Kinshasa XI, République démocratique du Congo
| |
Collapse
|
24
|
Kuntima Diasiama PD, Moningo Molamba D, Makulo Rissasy JR, Sumaili Kiswaya E, Mafuta Musalu É, Ngoma A, Loposso Nkumu M, Punga-Maole A, Lwa Nkandi SL, Haymann JP, Daudon M. [Chemical composition of urinary stones and associated factors in the Democratic Republic of Congo]. Nephrol Ther 2021; 17:441-450. [PMID: 34187760 DOI: 10.1016/j.nephro.2021.04.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2020] [Revised: 03/10/2021] [Accepted: 04/16/2021] [Indexed: 11/30/2022]
Abstract
To compare the chemical composition of the upper and lower urinary tract stones in Congolese patients, and to identify factors associated with the different types of stones. Stones from 119 patients originating from the upper tract and 75 from the lower tract were analyzed by infrared spectrophotometry. Among 119 patients with upper tract stones, age ranged from 10 to 81 years with a mean (SD) of 45.8 (13.6) years; males were the majority (55.5%). The main types of stones identified were whewellite (79%). For the 75 patients with lower apparatus stones, age ranged from 4 to 87 years with a mean (SD) of 51.6 (21.6) years; the majority were males (89.3%). The main types of stones were whewellite (44%) and anhydrous uric acid (22.7%). Overall, the factors associated with calcium oxalate included: site [4.95 (95% CI 2.35-10.44)] and diameter [3.03 (95% CI 1.45-6.25)]; patient's place of residence [0.05 (95% CI 0.01-0.29)] was associated with calcium phosphate. Infection stones were associated with; site [0.19 (95% CI 0.06-0.63)] and diameter [0.10 (95% CI 0.03-0.38)]. Finally, age 0.26 (95% CI 0.09-0.71) and stone site [0.23 (95% CI 0.07-0.68)] were associated with uric stones. The epidemiological and chemical profile of upper and lower tract stones were different. Several factors were associated with the chemical and crystalline composition of stones in the Democratic Republic of Congo.
Collapse
Affiliation(s)
| | - Dieudonné Moningo Molamba
- Service d'urologie, cliniques universitaires de Kinshasa, BP 123, Kinshasa 11, République démocratique du Congo
| | - Jean-Robert Makulo Rissasy
- Service de néphrologie, cliniques universitaires de Kinshasa, BP 123, Kinshasa 11, République démocratique du Congo
| | - Ernest Sumaili Kiswaya
- Service de néphrologie, cliniques universitaires de Kinshasa, BP 123, Kinshasa 11, République démocratique du Congo
| | - Éric Mafuta Musalu
- École de Santé publique, Université de Kinshasa, BP 123, Kinshasa 11, République démocratique du Congo
| | - Alain Ngoma
- Service de biologie médicale, cliniques universitaires de Kinshasa, BP 123, Kinshasa 11, République démocratique du Congo
| | - Mathieu Loposso Nkumu
- Service d'urologie, cliniques universitaires de Kinshasa, BP 123, Kinshasa 11, République démocratique du Congo
| | - Augustin Punga-Maole
- Service d'urologie, cliniques universitaires de Kinshasa, BP 123, Kinshasa 11, République démocratique du Congo
| | - Simon Lufuma Lwa Nkandi
- Service d'urologie, cliniques universitaires de Kinshasa, BP 123, Kinshasa 11, République démocratique du Congo
| | - Jean-Philippe Haymann
- Service des explorations fonctionnelles, Hôpital Tenon, 75970 Paris cedex 20, France
| | - Michel Daudon
- Service des explorations fonctionnelles, Hôpital Tenon, 75970 Paris cedex 20, France
| |
Collapse
|
25
|
Abstract
Artificial Intelligence can be leveraged to analyze great amounts of data. It can be used on images or textual data to define the epidemiology of diseases, such as cancer. In this review, we will present and discuss the applications of AI in this setting.
Collapse
|
26
|
Bigoteau M, Massot M, Baudet JM, Pasco J, Pichard T, Slim M, Bourges JL, Pisella PJ, Khanna RK. [Epidemiology of ocular emergencies in a non-university hospital: Clinical characteristics and severity grading according to the Base Score]. J Fr Ophtalmol 2021; 44:813-821. [PMID: 33965273 DOI: 10.1016/j.jfo.2020.08.036] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2020] [Revised: 06/24/2020] [Accepted: 08/11/2020] [Indexed: 11/30/2022]
Abstract
OBJECTIVE This study aimed to analyse the epidemiological characteristics of ophthalmological emergencies at the Bourges Medical Center (CHB) and to identify factors associated with severity according to the Base Score in a region of France considered a healthcare desert. METHODS All consecutive charts of patients seen for an eye-related condition between January 1 and April 30, 2019 in the ocular emergency department of the CHB were studied retrospectively. Seven demographic and nine medical variables were collected, and ocular severity was defined according to the Base Score. Linear regressions were performed to identify the factors associated with higher severity. RESULTS 1809 patients were included (mean age: 53.3±22.7 years, 51.4% women), of whom 1619 (89.5%) were self-referred. Ocular surface disease (12.5%) was the most frequent diagnosis. The severity of the eye-related condition was significantly associated with the following factors: male gender, distance from home to the emergency department, presentation soon after the onset of symptoms, and referral from a physician (ophthalmologist or not). The regression coefficient was greater than 1 only for the patient referral pattern. CONCLUSION The current study highlights that when patients with ocular emergencies can self-refer to an ocular emergency department within a French healthcare desert, 9 patients out of 10 self-refer. Referral from a physician is the main factor associated with ocular severity; thus, these cases should be considered severe until proven otherwise.
Collapse
Affiliation(s)
- M Bigoteau
- Service d'ophtalmologie, Centre hospitalier universitaire régional de Bretonneau, Tours, France; Service d'ophtalmologie, Centre hospitalier Jacques-Cœur, Bourges, France
| | - M Massot
- Département d'information médicale, Centre hospitalier Jacques-Cœur, Bourges, France
| | - J-M Baudet
- Service d'ophtalmologie, Centre hospitalier Jacques-Cœur, Bourges, France
| | - J Pasco
- Département d'information médicale, Centre hospitalier universitaire régional de Bretonneau, Tours, France
| | - T Pichard
- Service d'ophtalmologie, Centre hospitalier Jacques-Cœur, Bourges, France
| | - M Slim
- Service d'ophtalmologie, Centre hospitalier Jacques-Cœur, Bourges, France
| | - J-L Bourges
- Service d'ophtalmologie, Université de Paris, Faculté de médecine Paris Descartes, hôpital Cochin, AP-HP, Paris, France
| | - P-J Pisella
- Service d'ophtalmologie, Centre hospitalier universitaire régional de Bretonneau, Tours, France
| | - R K Khanna
- Service d'ophtalmologie, Centre hospitalier universitaire régional de Bretonneau, Tours, France.
| |
Collapse
|
27
|
Zarka M, Tretarre B, Rebillard X, Murez T, Daures JP, Azria D, Serre I, Brel D, Ramay AS, Reis Borges R, Gevorgyan A, Hutin M, Marchal S, Korahanis N, Iborra F, Thuret R. [Cancers of the external genital organs of male in Hérault: Results from the Hérault tumor register (RTH) over a period of 30 years (1987-2016)]. Prog Urol 2021; 31:282-292. [PMID: 33593695 DOI: 10.1016/j.purol.2020.08.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2020] [Revised: 07/25/2020] [Accepted: 08/13/2020] [Indexed: 10/22/2022]
Abstract
AIM The objective of this study is to present the history of cancers of the external genital organs of male in Hérault using data from the Hérault tumor register (RTH) over a period of 30 years. PATIENTS AND METHODS Using the RTH database, we studied the development of testicular germ cell tumors (TGCT) and penile cancer (PC) over 30 years, from 1987 to 2016. We analyzed the incidence and mortality data for these tumors. We compared these results to French, European and global data. RESULTS In 30 years of registration we have recorded 725 cases of TGCT and 175 cases of PC. The age standardized incidence rate (ASR) of TGCT has doubled between 1987 and 2016 (4.2 per 100,000 in 1987 and 9.3 per 100,000 in 2016). It was multiplied by 2.63 in the population of patients aged 30 to 44. There is a decrease of the mortality rate with a ASR of 0.8 deaths per 100,000 in 1987, and 0.4/100 000 in 2016. The PC incidence ASR was stable between 1987 and 2016 (0.4-0.9/100,000). Mortality is stable with a ASR between 0.1 and 0.3 deaths per 100,000 between 1987 and 2016. CONCLUSION The incidence of TGCT has increased sharply in the Hérault over the past 30 years, while a decrease in mortality has been observed. The proportion of seminomas is increasing; it has gone from 53 % to 60 % in 30 years in the Hérault. The incidence and mortality of PC shows a stability in the Hérault over the past 30 years.
Collapse
Affiliation(s)
- M Zarka
- Service d'urologie et transplantation rénale, CHU Montpellier Lapeyronie, 371, avenue du Doyen Gaston-Giraud, 34090 Montpellier, France.
| | - B Tretarre
- Registre des tumeurs de l'Hérault, Montpellier, France
| | - X Rebillard
- Service d'urologie, clinique beau soleil, Montpellier, France
| | - T Murez
- Service d'urologie et transplantation rénale, CHU Montpellier, Montpellier, France
| | - J P Daures
- Clinique beau soleil, IURC, Montpellier, France
| | - D Azria
- ICM, Univ Montpellier, inserm U 1194, Montpellier, France
| | - I Serre
- Service d'anatomopathologie, CHU Montpellier, Montpellier, France
| | - D Brel
- Service d'anatomopathologie, CH Béziers, Béziers, France
| | - A S Ramay
- Laboratoire de biologie médicale Medipath, Montpellier, France
| | - R Reis Borges
- Laboratoire de biologie médicale Labosud-Ob Biologie, Montpellier, France
| | - A Gevorgyan
- Polyclinique Saint-Privat, Boujan sur Libron, France
| | - M Hutin
- Service d'urologie, clinique beau soleil, Montpellier, France
| | - S Marchal
- Clinique du parc, Castelnau-le-lez, France
| | | | - F Iborra
- Service d'urologie et transplantation rénale, CHU Montpellier, Montpellier, France
| | - R Thuret
- Service d'urologie et transplantation rénale, CHU Montpellier, Montpellier, France
| | | |
Collapse
|
28
|
Guérinet L, Tournier M. [Euthanasia and assisted suicide for psychiatric disorder]. Encephale 2021; 47:246-253. [PMID: 33583568 DOI: 10.1016/j.encep.2020.10.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2020] [Revised: 10/08/2020] [Accepted: 10/19/2020] [Indexed: 12/28/2022]
Abstract
OBJECTIVES Assisted death has been discussed for years in medicine. Ten countries have adopted legislation that authorises some form of euthanasia or assisted suicide, and the incidence and practices vary from country to country. Consideration of psychological pain linked to psychiatric disorders as a sufficient legal condition for enabling assisted death has added a new layer of complexity to the debate. Thus, Switzerland, Netherlands, Belgium and Luxembourg legalised assisted suicide or euthanasia for psychiatric reasons. In these cases, it is not a question of choosing death conditions but the occurrence of death. This manuscript is a narrative review of the literature about characteristics of patients with psychiatric disorders who requested assisted death in these countries. METHODS Scientific manuscripts, reports and legal documents were reviewed. RESULTS The incidence of assisted death for psychiatric reasons was low but has increased over the years. They represented 1.1 % of assisted deaths in Belgium (n=23) and 1.3 % in Netherlands (n=83) in 2017, and 4.5 % in Switzerland in 2014 when also considering dementia. The most frequent diagnoses were depressive and personality disorders. Patients were more often women than men, unlike suicide and middle aged. CONCLUSIONS Authors who support these practices emphasise the right to die with dignity and the inequality of ruling out patients with psychiatric reasons, whereas they meet the legal requirements, and psychological pain is as severe as somatic pain. Some major issues are highlighted: the close relationship between mood symptoms and death wish, thinking biases and cognitive disturbances that limit the ability to decide, access and consent to medical care, the difficulty of assessing psychological pain, and the definitions of incurability or treatment refractoriness in psychiatry. To date, medical knowledge and assessment tools are not sufficient to define possible indications and offer the best support possible to these patients.
Collapse
Affiliation(s)
- L Guérinet
- Université de Bordeaux, 146, rue Léo Saignat, 33076 Bordeaux cedex, France
| | - M Tournier
- Université de Bordeaux, 146, rue Léo Saignat, 33076 Bordeaux cedex, France; Université de Bordeaux, Inserm Bordeaux Population Health Research Centre, équipe pharmaco-épidémiologie, UMR 1219, 146, rue Léo Saignat, 33076 Bordeaux cedex, France; Centre hospitalier Charles-Perrens, 121, rue de la Béchade, 33076 Bordeaux cedex, France.
| |
Collapse
|
29
|
Gherras M, Jany B. [Comparison of visual acuity, complications and patient satisfaction between outpatient and inpatient keratoplasty surgery]. J Fr Ophtalmol 2021; 44:559-563. [PMID: 33516574 DOI: 10.1016/j.jfo.2020.05.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2020] [Revised: 05/12/2020] [Accepted: 05/28/2020] [Indexed: 11/19/2022]
Abstract
INTRODUCTION Our objective in this work was to compare visual acuity, complication rate, rate of unplanned visits in the month following the procedure, and patient satisfaction between patients who received a corneal transplant as an outpatient or inpatient. PATIENTS AND METHODS Our work focused on 19 patients (6 inpatients and 13 outpatients), who had undergone unilateral keratoplasty between May 2018 and December 2018. The indications for corneal transplant were keratoconus, Fuchs dystrophy and graft rejection. RESULTS All patients who were followed for at least one month had an improvement in their VA. There were on average as many postoperative consultations in the inpatient group as in the outpatient group. Complications occurred in 77% of inpatients versus 40% of outpatients. The rate of consultations in the month following the operation was similar in both groups. Patients were satisfied with outpatient management. DISCUSSION No similar studies have been conducted to our knowledge. This preliminary work is limited by the small number of patients and questionnaires received and the length of follow-up. The criteria for outpatient care are very important to limit complications. For corneal transplantation, hospitalisation is most often performed with an average stay of 2 to 5 days. Outpatient management seems, according to our preliminary work, to be able to be extended into more centres without changing the postoperative follow-up or increasing the rate of complications, allowing lower cost and patient satisfaction. CONCLUSION The previous lack of this type of study, as well as the encouraging results of this work, open the way to larger scale prospective comparative as well as medico-economic studies.
Collapse
Affiliation(s)
- M Gherras
- CHU d'Amiens-Picardie, 1, rue du Professeur-Christian-Cabrol, 80054 Amiens, France.
| | - B Jany
- CHU d'Amiens-Picardie, 1, rue du Professeur-Christian-Cabrol, 80054 Amiens, France
| |
Collapse
|
30
|
Hutin M, Trétarre B, Gras C, Bessaoud F, Daurès JP, Delbos O, Bringer JP, Ayuso D, Thuret R, Azria D, Serre I, Brel D, Reis Borges R, Iborra F, Rébillard X. [Renal cell carcinoma in the department of Hérault: Results over a 30 year period]. Prog Urol 2020; 31:175-182. [PMID: 33160850 DOI: 10.1016/j.purol.2020.10.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2020] [Revised: 07/17/2020] [Accepted: 10/07/2020] [Indexed: 01/22/2023]
Abstract
OBJECTIVE The objective of the study was to determine the specificities of renal cell carcinoma (RCC) in the department of Herault using the Herault Tumor Registry over 30 years. METHODS Data of this study were obtained from the Herault cancer database. We analysed the evolution of RCC from 1987 to 2016, including the incidence, mortality, cancer pathology and staging at the moment of diagnosis. We compared our results with national and international data. RESULTS We identified 3769 newly diagnosed RCC: 2628 in men (69,7%) and 1141 in women (30,3%). In 2016, RCC was the 8th most frequent cancer, both genders combined, the 7th most frequent cancer in men and the 11th in women. New cases of RCC increased by 4.2 in men and 3.3 in women over the study period. The number of localised forms increased by 9% over 20 years. In 2016, the probability of having a RCC before the age of 75 was of 2.11% for a man and of 0.62% for a woman. CONCLUSION Over 30 years, the incidence rate of RCC increased in the department of Herault; however, mortality decreased over the same period. This analytical data should be improved by the development of the Registry of Herault Specialised in Onco-Urology (RHESOU). LEVEL OF EVIDENCE 3.
Collapse
Affiliation(s)
- M Hutin
- Service d'urologie, Clinique Beau Soleil, 119, avenue de Lodève, 34070 Montpellier, France; Service d'urologie, Centre Hospitalier Intercommunal du Bassin de Thau, boulevard Camille Blanc, 34200 Sète, France.
| | - B Trétarre
- Registre des Tumeurs de l'Hérault, 208, rue des Apothicaires, 34298 Montpellier Cedex 5, France
| | - C Gras
- Registre des Tumeurs de l'Hérault, 208, rue des Apothicaires, 34298 Montpellier Cedex 5, France
| | - F Bessaoud
- Registre des Tumeurs de l'Hérault, 208, rue des Apothicaires, 34298 Montpellier Cedex 5, France
| | - J-P Daurès
- Service d'urologie, Clinique Beau Soleil, 119, avenue de Lodève, 34070 Montpellier, France; Registre des Tumeurs de l'Hérault, 208, rue des Apothicaires, 34298 Montpellier Cedex 5, France
| | - O Delbos
- Urodoc, 265, avenue des Etats du Languedoc, 34000 Montpellier, France
| | - J-P Bringer
- Polyclinique Saint Privat, rue de la Margeride, 34760 Boujan-sur-Libron, France; Centre Hospitalier de Béziers, 2, rue Valentin Hauy, 34500 Béziers, France
| | - D Ayuso
- Service d'urologie, Centre Hospitalier Intercommunal du Bassin de Thau, boulevard Camille Blanc, 34200 Sète, France
| | - R Thuret
- Centre Hospitalier Universitaire Lapeyronie, 371, avenue du Doyen Gaston Giraud, 34090 Montpellier, France
| | - D Azria
- Registre des Tumeurs de l'Hérault, 208, rue des Apothicaires, 34298 Montpellier Cedex 5, France; Institut du Cancer de Montpellier, 208, avenue des Apothicaires, 34298 Montpellier, France
| | - I Serre
- Centre Hospitalier Universitaire Lapeyronie, 371, avenue du Doyen Gaston Giraud, 34090 Montpellier, France
| | - D Brel
- Centre de pathologie Biterrois, 101, avenue Jean-Moulin, 34500 Béziers, France
| | - R Reis Borges
- Inopath Labosud Alco, 141, avenue Paul-Bringuier, 34080 Montpellier, France
| | - F Iborra
- Registre des Tumeurs de l'Hérault, 208, rue des Apothicaires, 34298 Montpellier Cedex 5, France; Centre Hospitalier Universitaire Lapeyronie, 371, avenue du Doyen Gaston Giraud, 34090 Montpellier, France
| | - X Rébillard
- Service d'urologie, Clinique Beau Soleil, 119, avenue de Lodève, 34070 Montpellier, France; Registre des Tumeurs de l'Hérault, 208, rue des Apothicaires, 34298 Montpellier Cedex 5, France
| | | |
Collapse
|
31
|
Ben Ahmed H, Ben Khelil M, Bellali M, Shimi M, Belhaj A, Allouche M, Allouche E, Razghallah R, Banasr A, Benzarti A, Hamdoun M. [Sudden cardiac death in women, data from the northern Tunisian sudden cardiac-death registry]. Ann Cardiol Angeiol (Paris) 2020; 70:1-6. [PMID: 33109353 DOI: 10.1016/j.ancard.2020.10.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2020] [Accepted: 10/04/2020] [Indexed: 11/29/2022]
Abstract
BACKGROUND Sudden cardiac death is a major public health problem. Epidemiological and clinical differences according to gender have been described in sudden cardiac death. The aim of this study was to examine the gender differences between autopsy findings and circumstance of occurrence associated with sudden cardiac death. METHODS We prospectively collected epidemiological and autopsy data of victims of sudden cardiac death occurring in the northern governorates of Tunisia between January 2013 and December 2019. Symptoms preceding death, circadian, weekly and seasonal variations of sudden death were also analyzed. RESULTS The study population included 1834 men and 468 women with a mean age of 56.5±14.2 years. All cardiovascular risk factors except smoking were significantly more frequent among women but ischemic heart disease was the most common cause of death in men (51.3 %, versus 28 %, P<0.001). Women were more likely to have a negative macroscopic autopsy than men (34 % versus 23.6 %, P<0.001). Chest pain preceding sudden death was more frequent in male (24 % versus 13.2 %, P<0.001). In contrast, women were more likely to have dyspnea (8.1 % versus 15.6 %, P<0.001). Sudden death in women occurred indoors more often than in men (63.9 % versus 54.5 %, P<0.001) and also more often during night (midnight to 6 am). We also recorded an excess cardiac mortality in winter in both sexes. CONCLUSIONS Women had considerably more cardiovascular risk factors and more commonly negative macroscopic autopsy. Death occurred indoors and during night more often than in men.
Collapse
Affiliation(s)
- H Ben Ahmed
- Service de cardiologie, hôpital Charles-Nicolle, faculté de médecine, université Tunis-El-Manar, 2092 Tunis, Tunisie.
| | - M Ben Khelil
- Service de médecine légale, hôpital Charles-Nicolle, faculté de médecine, université Tunis-El-Manar, 2092 Tunis, Tunisie
| | - M Bellali
- Service de médecine légale, hôpital Charles-Nicolle, faculté de médecine, université Tunis-El-Manar, 2092 Tunis, Tunisie
| | - M Shimi
- Service de médecine légale, hôpital Charles-Nicolle, faculté de médecine, université Tunis-El-Manar, 2092 Tunis, Tunisie
| | - A Belhaj
- Service de médecine légale, hôpital Charles-Nicolle, faculté de médecine, université Tunis-El-Manar, 2092 Tunis, Tunisie
| | - M Allouche
- Service de médecine légale, hôpital Charles-Nicolle, faculté de médecine, université Tunis-El-Manar, 2092 Tunis, Tunisie
| | - E Allouche
- Service de cardiologie, hôpital Charles-Nicolle, faculté de médecine, université Tunis-El-Manar, 2092 Tunis, Tunisie
| | - R Razghallah
- Service de cardiologie, hôpital Charles-Nicolle, faculté de médecine, université Tunis-El-Manar, 2092 Tunis, Tunisie
| | - A Banasr
- Service de médecine légale, hôpital Charles-Nicolle, faculté de médecine, université Tunis-El-Manar, 2092 Tunis, Tunisie
| | - A Benzarti
- Service de médecine légale, hôpital Charles-Nicolle, faculté de médecine, université Tunis-El-Manar, 2092 Tunis, Tunisie
| | - M Hamdoun
- Service de médecine légale, hôpital Charles-Nicolle, faculté de médecine, université Tunis-El-Manar, 2092 Tunis, Tunisie
| |
Collapse
|
32
|
Rubin S, Boulestreau R, Couffinhal T, Combe C, Girerd X. [Impaired hypertension control in France: What the nephrologist needs to know]. Nephrol Ther 2020; 16:347-352. [PMID: 33069630 DOI: 10.1016/j.nephro.2020.10.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2020] [Revised: 09/29/2020] [Accepted: 10/01/2020] [Indexed: 01/13/2023]
Abstract
In France, 1 adult out of 3 is affected by hypertension and only 1 hypertensive out of 4 achieves blood pressure targets (<140/90mmHg). This proportion is significantly better in similar countries (e.g. England, Germany, the USA). Nephrologists are particularly concerned since although more than 90 % of Chronic Kidney Disease (CKD) stages 3 and 4 patients are hypertensive, the CKD-REIN cohort shows that in France more than 1 out of 2 patients with CKD remains with a blood pressure above 140/90mmHg. This report, based on the latest French studies and surveys, raises an important warning about the situation in France, discusses the main reasons for these results and offers some suggestions for improvement. Otherwise we risk a dramatic increase in the incidence of myocardial infarction, stroke, dependency and dementia in the coming years.
Collapse
Affiliation(s)
- Sébastien Rubin
- Service de néphrologie, transplantation rénale, dialyse et aphérèses, hôpital Pellegrin, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France; Unité Inserm U1034, university Bordeaux, Bordeaux, France.
| | - Romain Boulestreau
- Service de cardiologie et hypertension artérielle, hôpital de Pau, 4, boulevard Hauterive, 64064 Pau, France
| | - Thierry Couffinhal
- Unité Inserm U1034, university Bordeaux, Bordeaux, France; Service de cardiologie, hôpital Haut-Lévêque, CHU de Bordeaux, avenue de Magellan, 33604 Pessac cedex, France
| | - Christian Combe
- Service de néphrologie, transplantation rénale, dialyse et aphérèses, hôpital Pellegrin, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France; Unité Inserm, U1026 BioTis, university Bordeaux, Bordeaux, France
| | - Xavier Girerd
- Fondation de recherche sur l'hypertension artérielle, 12, rue des Colonnes-du-Trône, 75012 Paris, France
| |
Collapse
|
33
|
Duroi Q, Leclerc C, Chardon JF, Le Lez ML, Khanna RK, Pisella PJ. [Screening for diabetic retinopathy in the Centre-Val de Loire region: A study based on the French national healthcare database]. J Fr Ophtalmol 2020; 43:1054-1061. [PMID: 33059944 DOI: 10.1016/j.jfo.2020.01.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2019] [Accepted: 01/23/2020] [Indexed: 10/23/2022]
Abstract
INTRODUCTION The main objective of this study was to investigate the rate of ophthalmological screening for diabetic retinopathy in diabetic individuals in the Centre-Val de Loire (CVDL) region. This study secondarily aimed to identify factors associated with regular ophthalmological screening. MATERIAL AND METHODS Data were extracted from the French national healthcare database (SNDS). Individuals were identified on the basis of reimbursements for antidiabetic medications. Patients who were identified as having at least one reimbursed eye examination between 2015 and 2016 were considered as having regular follow-up. RESULTS In total, 118,181 diabetic individuals residing in CVDL were identified in the SNDS, and 74,048 had undergone ophthalmological screening. The rate of eye examination was 62.7% between 2015 and 2016 and was highly variable within the region (from 65.6% in Loiret to 54.0% in Cher). The main factors associated with regular eye screening were: follow-up with an established primary care physician (OR=2.88), regular follow-up with a diabetologist (OR=2.14), and regular follow-up with an internist (OR=1.57). CONCLUSION This study suggests that ophthalmological screening for diabetic retinopathy in individuals with diabetes in the CVDL region could be significantly improved, particularly in rural areas. Factors influencing compliance with follow-up are multiple but appear mainly related to the patients' quality of overall medical management. These findings highlight the need for public health policies to improve detection and prevention of diabetic retinopathy by promoting comprehensive medical care for diabetic individuals.
Collapse
Affiliation(s)
- Q Duroi
- Service d'ophtalmologie, CHRU Bretonneau, 2, boulevard Tonnellé, 37044 Tours cedex 9, France.
| | - C Leclerc
- Observatoire régionale de la santé du Centre-Val de Loire, 1, bis rue porte Madeleine, 45000 Orléans, France
| | - J-F Chardon
- Direction régionale du service médical Centre-Val de Loire, 25, boulevard Jean-Jaurès, 45016 Orléans cedex 1, France
| | - M-L Le Lez
- Service d'ophtalmologie, CHRU Bretonneau, 2, boulevard Tonnellé, 37044 Tours cedex 9, France
| | - R K Khanna
- Service d'ophtalmologie, CHRU Bretonneau, 2, boulevard Tonnellé, 37044 Tours cedex 9, France
| | - P-J Pisella
- Service d'ophtalmologie, CHRU Bretonneau, 2, boulevard Tonnellé, 37044 Tours cedex 9, France
| |
Collapse
|
34
|
Bentellis I, Colomb F, Drogrey M, Canac B, Tibi B, Ahallal Y, Mendel L, Shaikh A, Amiel J, Levraut J, Chevallier D, Durand M. [Assessment of a post-emergency pathway with early urological regulation]. Prog Urol 2020; 30:1051-9. [PMID: 33055003 DOI: 10.1016/j.purol.2020.06.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2020] [Revised: 05/09/2020] [Accepted: 06/13/2020] [Indexed: 11/23/2022]
Abstract
INTRODUCTION Urological emergencies represent 7 % of the outpatients at the emergency department (ED). We assessed the effect of setting up a post-emergency consultation (CPU) after deferred urological medical regulation. METHODS All patients admitted to the ED in a university center over the period December 2017 to July 2018 and for whom a CPU was scheduled were included. The regulation concerned the date of CPU and supplementary exams. The main outcome was the ability to provide an efficient response according to a predefined grid of specific solutions. RESULTS One hundred and twenty-eight patients were included. The median age was 57 years (18-97). Efficacy of the CPU was 76 %. This rate was lower in no-show patients or consulting for rare and complex motives (47 %, n=60). The no-show were not reachable on the first call in 51.6 % of cases, with a similar age and motives distribution to the others. Only 6,9 % (n=128) of all consultants (n=1863) had been referred to the CPU by emergency physicians. The decision was a second consultation in 70 % (48), a new exam in 10 % (7), deferred emergency surgery in 12 % (8) and finally 18 % (12) of no follow-up. CONCLUSION CPU following early regulation by a urologist provides an effective response in 76 % of situations. Assessment of "no-shows" helped to identify groups at risk. LEVEL OF EVIDENCE III.
Collapse
|
35
|
Jourdes A, Lafaurie M, Martin-Blondel G, Delobel P, Faruch M, Charpentier S, Minville V, Silva S, Thalamas C, Sommet A, Moulis G. Clinical characteristics and outcome of hospitalized patients with SARS-CoV-2 infection at Toulouse University hospital (France). Results from the Covid-clinic-Toul cohort. Rev Med Interne 2020; 41:732-740. [PMID: 33077266 PMCID: PMC7540209 DOI: 10.1016/j.revmed.2020.08.006] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2020] [Revised: 08/06/2020] [Accepted: 08/29/2020] [Indexed: 01/08/2023]
Abstract
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has spread worldwide from epicenter of Wuhan, China since December 2019. The aim of our study was to describe the clinical characteristics and outcome of hospitalized patients with SARS-CoV-2 pneumonia at the Toulouse university hospital, France. Patients and methods We selected the patients included from March 7, 2020 to April 20, 2020 in the retrolective Covid-clinic-Toul cohort that follows all hospitalized patients with SARS-CoV-2 infection at the Toulouse Hospital. Cases were confirmed by real-time reverse transcriptase polymerase chain reaction. We report demographics, clinical, biological and radiological features, as well as unfavorable outcome at Day 14 after admission (admission in an intensive care unit, mechanical ventilation, death). Results Among 263 hospitalized patients, the median age was 65 years and 155 (58.9%) were males. Two hundred and twenty-seven patients (86.3%) had at least one comorbidity. The median time from first symptom to hospital admission was 7.0 days (interquartile range: 4–10). On day 14 after admission, 111 patients (42.2%) had been transferred to intensive care unit (ICU), including 50 (19.0%) on Day 1; 61 (23.1%) needed mechanical ventilation and 19 patients (7.2%) had died. Patients admitted to ICU at Day 1 of admission (n = 50) were more frequently men (66.0% vs 57.3%), smokers (25.0% vs 7.1%), with obesity (42.0% vs 24.7%) and had a higher mean level of C-reactive protein (median: 110.9 mg/L vs 46.2 mg/L). Conclusion This cohort provides epidemiological data on SARS-CoV-2 in hospitalized patients in a University hospital in the South of France.
Collapse
Affiliation(s)
- A Jourdes
- Service des maladies infectieuses et tropicales, CHU de Toulouse, Toulouse, France
| | - M Lafaurie
- Centre d'investigation clinique 1436, CHU de Toulouse, Toulouse, France; Service de pharmacologie médicale et clinique, CHU de Toulouse, Toulouse, France.
| | - G Martin-Blondel
- Service des maladies infectieuses et tropicales, CHU de Toulouse, Toulouse, France
| | - P Delobel
- Service des maladies infectieuses et tropicales, CHU de Toulouse, Toulouse, France
| | - M Faruch
- Service de radiologie et imagerie médicale, CHU de Toulouse, Toulouse, France
| | - S Charpentier
- Service des urgences, CHU de Toulouse, Toulouse, France
| | - V Minville
- Service de réanimation, CHU de Toulouse, Toulouse, France
| | - S Silva
- Service de réanimation, CHU de Toulouse, Toulouse, France
| | - C Thalamas
- Centre d'investigation clinique 1436, CHU de Toulouse, Toulouse, France; Service de pharmacologie médicale et clinique, CHU de Toulouse, Toulouse, France
| | - A Sommet
- Centre d'investigation clinique 1436, CHU de Toulouse, Toulouse, France; Service de pharmacologie médicale et clinique, CHU de Toulouse, Toulouse, France
| | - G Moulis
- Centre d'investigation clinique 1436, CHU de Toulouse, Toulouse, France; Service de médecine interne, CHU de Toulouse, Toulouse, France
| |
Collapse
|
36
|
Trouche-Sabatier SG, Rebillard X, Iborra F, Azria D, Daures JP, Poinas G, Abdo N, Delbos O, Gevorgyan A, Marchal S, Guillon R, Millet I, Lamy PJ, Lauche O, Reis-Borges R, Serre I, Topart D, Tretarre B. [RHESOU (Registry in HErault Specialized in Onco-Urology) : the first French Registry specialized in Onco-Urology. One-year experience]. Prog Urol 2020; 30:1038-1044. [PMID: 33012630 DOI: 10.1016/j.purol.2020.09.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2020] [Revised: 08/13/2020] [Accepted: 09/06/2020] [Indexed: 10/23/2022]
Abstract
PURPOSE In 2016, the Herault tumor registry collected 1961cancers in urology (21.4 % from all Herault cancers this year). RHESOU was created to complete RTH' data with specific parameters in onco-urology. The aim of this study is to describe RHESOU and to give some examples with our first results. MATERIAL AND METHODS In November 2018, RHESOU (Registry HErault Specialised in Onco-Urology) was founded with the same registry recommendations. It collects specific oncologic parameters and also complete RTH's data. For each urological cancer, a specific survey with different choices was performed to collect a maximum of data which could be present in patients' file. These surveys were used for urological cancers cases that live in Herault in 2017. RESULTS In 2017, we collected 970 prostate cancers, 581 bladder cancers, 212 kidney cancers, 51 upper excretory tract cancers, 28 testicle cancers and 9 penil cancers. Our urological data collection gives many possibilities to create many requests for detailed analysis in urological cancers. In this article, we reported data from kidney, bladder and prostate cancers. CONCLUSIONS RHESOU is a new tool opened to the different urologic corporations (urologists, pathologists, oncologists, radiotherapists, radiologists) that permits an overview in urological cancers in Herault. Finally, one important aim is that this tool will be adapted when new treatments or new important parameters appear in the years ahead. LEVEL OF EVIDENCE 3.
Collapse
Affiliation(s)
| | - X Rebillard
- Comité de pilotage, Montpellier, France; Clinique Beau Soleil, Montpellier, France
| | - F Iborra
- Comité de pilotage, Montpellier, France; CHU de Montpellier, Montpellier, France
| | - D Azria
- Comité de pilotage, Montpellier, France; Inserm U 1194, ICM, université Montpellier, Montpellier, France
| | - J-P Daures
- Comité de pilotage, Montpellier, France; Clinique Beau Soleil, Montpellier, France; IURC, Montpellier, France
| | - G Poinas
- Comité scientifique du RHESOU, Montpellier, France; Clinique Beau Soleil, Montpellier, France
| | - N Abdo
- Comité scientifique du RHESOU, Montpellier, France; CHU de Montpellier, Montpellier, France
| | - O Delbos
- Comité scientifique du RHESOU, Montpellier, France; Urodoc, Montpellier, France
| | - A Gevorgyan
- Comité scientifique du RHESOU, Montpellier, France; Polyclinique Saint-Privat Boujan sur Libron, Béziers, France
| | - S Marchal
- Comité scientifique du RHESOU, Montpellier, France; Urodoc, Montpellier, France
| | - R Guillon
- Comité scientifique du RHESOU, Montpellier, France; Clinique Beau Soleil, Montpellier, France
| | - I Millet
- Comité scientifique du RHESOU, Montpellier, France; CHU de Montpellier, Montpellier, France
| | - P-J Lamy
- Comité scientifique du RHESOU, Montpellier, France; Imagenome-inovie, Montpellier, France
| | - O Lauche
- Comité scientifique du RHESOU, Montpellier, France; Clinique Clémentville, Montpellier, France
| | - R Reis-Borges
- Comité scientifique du RHESOU, Montpellier, France; Inopath Labosud, Montpellier, France
| | - I Serre
- Comité scientifique du RHESOU, Montpellier, France; CHU de Montpellier, Montpellier, France
| | - D Topart
- Comité scientifique du RHESOU, Montpellier, France; CHU de Montpellier, Montpellier, France
| | - B Tretarre
- Comité de pilotage, Montpellier, France; Registre des tumeurs de l'Hérault, Montpellier, France
| | | |
Collapse
|
37
|
Cissé M, Zida A, Diallo AH, Marty P, Aoun K. [Epidemiology of Cutaneous Leishmaniasis in West Africa: a Systematic Review]. ACTA ACUST UNITED AC 2020; 113:24-34. [PMID: 32881442 DOI: 10.3166/bspe-2020-0115] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2020] [Accepted: 03/16/2020] [Indexed: 11/20/2022]
Abstract
Cutaneous leishmaniasis (CL) has been described in West Africa (WA) since the beginning of the 20th century. The incidence of cases has markedly increased during the last decades in several countries of the region. Despite that, data remain scarce and fragmentary. The current incidence and geographic distribution of the disease as well as the involved vectors and reservoirs remain poorly documented. The objective of this review was to collect and analyze available data about CL in WA in order to improve the management of cases and the control of the disease transmission. A systematic literature review was performed using the Pubmed, Google Scholar and Hinari databases. Publications focusing on epidemiological aspects of CL, involved parasite species, sand flies and potential reservoir hosts were searched without any restrictions. Unpublished studies were extracted from Google. Manuscripts without full text or summary available were excluded as well as those whose summaries did not contain any usable data. One hundred and fifteen studies were recorded. Among them, 93 filled selection criteria. CL has been reported in 10 West African countries with outbreaks described in five countries. Burkina Faso, where the average incidence of the disease is around 928 cases per year, and Ghana seem to be the most affected. Cases have been confirmed in the majority of studies by microscopy sometimes associated with culture or histology. The exposure rate to Leishmania infection based on leishmanin skin test was relatively high with an overall average of 30.2%. Leishmania major was the only species identified with a predominance of MON-74 (62%) and MON-26 (30.6%) zymodemes. Phlebotomus duboscqi is retained as the vector whereas Sergentomyia darlingi and Sergentomyia ingrami were found naturally infected. Rodents including Arvicanthis niloticus, Gerbilliscus gambiana and Mastomys spp. are reported as the main reservoir hosts. Additional studies are needed to better characterize CL in WA in order to optimize the management of cases and to organize the control of the disease transmission.
Collapse
Affiliation(s)
- M Cissé
- INSP/Centre MURAZ, Bobo-Dioulasso, Burkina Faso.,Université Nazi-Boni, Bobo-Dioulasso, Burkina Faso
| | - A Zida
- Université Professeur-Joseph-Kizerbo, Ouagadougou, Burkina Faso
| | - A Hama Diallo
- INSP/Centre MURAZ, Bobo-Dioulasso, Burkina Faso.,Université Professeur-Joseph-Kizerbo, Ouagadougou, Burkina Faso
| | - P Marty
- Service de parasitologie-mycologie, CHU de Nice, université Côte d'Azur, Inserm U 1065, 06202 Nice, France
| | - K Aoun
- Laboratoire d'épidémiologie et d'écologie parasitaire, institut Pasteur de Tunis, Tunis, Tunisie
| |
Collapse
|
38
|
Gas J, Dominique I, Mathieu R, Poinas G, Cuvelier G, Rebillard X, Corbel L. [Radical prostatectomy for prostate cancer, perioperative management by French urologists in 2018]. Prog Urol 2020; 30:541-546. [PMID: 32646841 DOI: 10.1016/j.purol.2020.06.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2020] [Revised: 06/17/2020] [Accepted: 06/22/2020] [Indexed: 11/26/2022]
Abstract
INTRODUCTION Prostatectomy (PT) is a common procedure performed by many urologists. In 2018, 20,207 prostatectomies were performed in France, and few studies evaluated the perioperative habits of urologists. As part of writing guidelines for enhanced recovery after surgery (ERAS) we wished to evaluate practice of urologists in their hospital management of a prostatectomy. MATERIEL AND METHODS A questionnaire was sent by Survey Monkey in June and July 2018 to all urologists who are members of the French Association of Urology. RESULTS One hundred and sixty seven urologists (14%) answered the questionnaire, 62% have private practice. The average number of operators per center performing PT was 4, with a median number of 70 interventions (0 to 486) per center in 2018. Open surgery is still gold standard (39.13%), followed by the robot-assisted transperitoneal laparoscopic (34.78%) and standard laparoscopic (24.22%). Alimentation, like first stand-up, was re-established on the first post-operative day, and the average hospital stay was 4±2 nights. The removal of the bladder catheter was most often performed at home by nurse (49.06%), one week after surgery. Only 10.06% of urologists systematically perform a cystography before removal urinary catheter. CONCLUSION The perioperative management of prostatectomy in France is relatively homogeneous, between urologists. The length of hospital stay remains important and could be reduced by proposing an ERAS protocol as has been obtained for cystectomy. LEVEL OF EVIDENCE III.
Collapse
Affiliation(s)
- J Gas
- Département d'urologie, andrologie et transplantation rénale, CHU de Toulouse, Toulouse, France
| | - I Dominique
- Service d'urologie, groupe hospitalier Diaconesses croix saint-Simon, Paris, France
| | - R Mathieu
- Service d'urologie, CHU de Rennes, Rennes, France
| | - G Poinas
- Service d'urologie, clinique Beausoleil, Montpellier, France
| | - G Cuvelier
- Service d'urologie, centre hospitalier de Cornouaille, Quimper, France
| | - X Rebillard
- Service d'urologie, clinique Beausoleil, Montpellier, France
| | - L Corbel
- Service d'urologie, hôpital privé des côtes d'Armor, Plerin, France
| | | |
Collapse
|
39
|
Grangé G, Berlin I, Bretelle F, Bertholdt C, Berveiller P, Blanc J, DiGuisto C, Dochez V, Garabedian C, Guerby P, Koch A, Le Lous M, Perdriolle-Galet E, Peyronnet V, Rault E, Torchin H, Legendre G. [CNGOF-SFT Expert Report and Guidelines for Smoking Management during Pregnancy-Short Text]. Gynecol Obstet Fertil Senol 2020; 48:539-545. [PMID: 32289497 DOI: 10.1016/j.gofs.2020.04.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
OBJECTIVES To provide up-to-date evidence-based guidelines for the management of smoking cessation during pregnancy. METHODS Systematic review of the international literature. We identified papers published between January 2003 and April 2019 in Cochrane PubMed, and Embase databases with predefined keywords. All reports published in French and English relevant to the areas of focus were included and classified according the level of evidence ranging from 1 (highest) to 4 (lowest). The strength of the recommendations was classified according to the Haute Autorité de santé, France (ranging from A, highest to C, lowest). RESULTS "Counseling", involving globally all kind of non-pharmacological interventions, has a modest benefit on smoking cessation, birth weight and prematurity. Moderate physical activity did not show a significant effect on smoking cessation. The systematic use of feedback by measuring the expired air carbon monoxide concentration do not influence smoking abstinence but it may be used in establishing a therapeutic alliance. The use of self-help interventions and health education are recommended in helping pregnant smokers quit. The prescription of nicotine replacement therapies (NRT) may be offered to any pregnant woman who has failed stopping smoking without medication This prescription can be initiated by the health care professional taking care of the pregnant woman in early pregnancy. There is no scientific evidence to propose the electronic cigarette for smoking cessation to pregnant smokers; it is recommended to provide the same advice and to use methods that have already been evaluated. The use of waterpipe (shisha/narghile) during pregnancy is associated with decreased fetal growth. It is recommended not to use waterpipe during pregnancy. Breastfeeding is possible in smokers, but less often initiated by them. Although its benefit for the child's development is not demonstrated to date, breastfeeding allows the mother to reduce or stop smoking. The risk of postpartum relapse is high (up to 82% at 1 year). The main factors associated with postpartum abstinence are breastfeeding, not having a smoker at home, and having no symptoms of postpartum depression. CONCLUSIONS Smoking during pregnancy concerns more than hundred thousand women and their children per year in France. It is a major public health burden. Health care professionals should be mobilized for reducing or even eradicating it.
Collapse
Affiliation(s)
- G Grangé
- Maternité Port-Royal, université de Paris, AP-HP, 75014 Paris, France.
| | - I Berlin
- Département de pharmacologie, AP-HP, 75000 Paris, France; Centre universitaire de médecine générale et de santé publique, 1000 Lausanne, Suisse
| | - F Bretelle
- Department of obstetrics and gynecology, conception hospital, Aix Marseille université, prenatal diagnosis Timone Conception, IHU, IRD, Assistance publique des Hôpitaux de Marseille (AP-HM), 13005 Marseille, France
| | - C Bertholdt
- Pôle de la femme, maternité régionale du CHRU de Nancy, 10, rue Dr-Heydenreich, 54000 Nancy, France; IADI, Inserm U1254, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France
| | - P Berveiller
- Service de gynécologie-obstétrique, CHI Poissy-St-Germain-en-Laye, 78300 Poissy, France
| | - J Blanc
- Service de gynécologie obstétrique, hôpital Nord, AP-HM, chemin des Bourrely, 13015 Marseille, France; EA3279, CEReSS, health service research and quality of life center, université Aix-Marseille, 13284 Marseille, France
| | - C DiGuisto
- Université de Paris, epidemiology and statistics research center/CRESS, Inserm (U1153 - Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé)), INRA, hôpital Tenon, bâtiment Recherche, rue de la Chine, 75020 Paris, France; Maternité Olympe de Gouges, centre hospitalier régional universitaire Tours, Tours, France; Université François-Rabelais, 37000 Tours, France
| | - V Dochez
- Service de gynécologie-obstétrique, CHU de Nantes, 44093 Nantes, France
| | - C Garabedian
- EA 4489 - Perinatal Environment and Health, université de Lille, hôpital Jeanne-de-Flandre, clinique d'obstétrique, CHU de Lille, 59000 Lille, France
| | - P Guerby
- Service de gynécologie obstétrique, hôpital Paule-de-Viguier, CHU de Toulouse, 330, avenue de Grande-Bretagne, 31059 Toulouse, France
| | - A Koch
- Service de gynécologie-obstétrique, CHU de Strasbourg, 67000 Strasbourg, France
| | - M Le Lous
- Département de gynécologie obstétrique et médecine de la reproduction, CHU de Rennes, Rennes, France; LTSI-Inserm, université de Rennes 1, UMR 1099, 35000 Rennes, France
| | - E Perdriolle-Galet
- Pôle de la femme, maternité régionale du CHRU de Nancy, 10, rue Dr-Heydenreich, 54000 Nancy, France
| | - V Peyronnet
- Service de gynécologie obstétrique, hôpital L.-Mourier, AP-HP, 92700 Colombes, France
| | - E Rault
- Hôpital Femme-Mère-Enfant, 69500 Bron, France
| | - H Torchin
- Service de médecine et réanimation néonatales de Port-Royal, AP-HP, 75014 Paris, France; Université de Paris, epidemiology and statistics research center/CRESS, Inserm, INRA, 75004 Paris, France
| | - G Legendre
- CESP-Inserm, U1018, Team 7, Genre, Sexual and Reproductive Health, Paris-Sud University, Paris-Saclay University, UVSQ, Inserm, 94800 Villejuif, France; Department of obstetrics and gynecology, Angers university hospital, 49000 Angers, France
| |
Collapse
|
40
|
Dochez V, Diguisto C. [Epidemiology and Risk Factors of Smoking During Pregnancy (Excluding Coaddictions) - CNGOF-SFT Expert Report and Guidelines for Smoking Management during Pregnancy]. Gynecol Obstet Fertil Senol 2020; 48:546-550. [PMID: 32247093 DOI: 10.1016/j.gofs.2020.03.024] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
World tobacco consumption during pregnancy is estimated to be 1.7% (95% CI: 0.0-4.5). Among the 50 European countries evaluated, France ranks 7th among the countries most affected by active smoking during pregnancy. In the 2016 National Perinatal Survey, 30.0% of women reported active smoking before they started their pregnancy and 16.6% still smoked in the 3rd trimester of pregnancy. There are also disparities in consumption between regions in France (24.0% of pregnant women with active smoking in the 3rd trimester of pregnancy in Brittany against 9.4% in the Paris region and 5.2% in the French departments and French overseas territories). A young age, a low level of education, a low socioeconomic level, primiparity, a geographical origin of mainland France, unemployment, a smoking partner, no partner or a depression are risk factors for smoking during pregnancy. Multiparity is a risk factor for failure of smoking cessation during pregnancy. For health professionals in contact with women of childbearing age, it is recommended to identify a tobacco consumption in women or their partners before pregnancy or as early as possible during pregnancy.
Collapse
Affiliation(s)
- V Dochez
- Service de gynécologie-obstétrique, centre hospitalier universitaire de Nantes, 44093 Nantes cedex 1, France.
| | - C Diguisto
- Service de gynécologie-obstétrique, maternité Olympe-de-Gouges, université François-Rabelais, centre hospitalier universitaire de Tours, 37044 Tours cedex 01, France
| |
Collapse
|
41
|
Pezel T, Lima JAC. The potential sudden shift in clinical research and epidemiology of cardiovascular diseases, caused by COVID-19. Arch Cardiovasc Dis 2020; 113:378-380. [PMID: 32586675 PMCID: PMC7303640 DOI: 10.1016/j.acvd.2020.05.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/19/2020] [Revised: 05/23/2020] [Accepted: 05/25/2020] [Indexed: 11/15/2022]
Affiliation(s)
- Théo Pezel
- Cardiology Division, Department of Medicine, Johns Hopkins University, 600 North Wolfe Street, 21287-0409 Baltimore, MD, USA; Department of Cardiology, Lariboisière Hospital, AP-HP, Inserm UMRS 942, University of Paris, 75010 Paris, France
| | - Joao A C Lima
- Cardiology Division, Department of Medicine, Johns Hopkins University, 600 North Wolfe Street, 21287-0409 Baltimore, MD, USA.
| |
Collapse
|
42
|
Saghatchian M, Curtit E, Coeffic D, Flinois A, Levy C. [Real-life study of 7-year survival in patients treated with trastuzumab for HER2+ early breast cancer]. Bull Cancer 2020; 107:745-755. [PMID: 32532419 DOI: 10.1016/j.bulcan.2020.04.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2020] [Revised: 04/18/2020] [Accepted: 04/22/2020] [Indexed: 10/24/2022]
Abstract
BACKGROUND AND RATIONALE Despite improved prognosis of HER2 since the introduction of trastuzumab in the adjuvant setting of early breast cancer, disease recurrences still occur, particularly in certain patient subgroups. The objective of this real-life study conducted in France is to evaluate after 7 years, disease-free survival (DFS) and distant metastatic-free survival (MFS). METHODS This was a multi-center, retrospective, observational study assessing early HER2+ breast cancer patients diagnosed between January 1st, 2009 and December 31st, 2010 treated with adjuvant trastuzumab. DFS and MFS were evaluated within subgroups according to hormonal and nodal status. RESULTS Based on 2311 patients documented, according to nodal status, the 7-year DFS rate was significantly higher for N- than for N+ patients [87.2% vs. 66.8%; P<0.001], and the 7-year MFS rate [94.7% for N- vs. 74.9% for N+; P<0.001]. According to hormonal status, the 7-year DFS rate was significantly higher for HR+ than for HR- patients [80.5% vs. 69.2%; P<0.001], and the 7-year MFS rate [88.0% for HR+ vs. 77.7% HR-]. CONCLUSIONS Despite the overall improvement in the prognosis of early HER2+ breast cancers, patients in the N+ and RH- subgroups have a high risk of metastatic recurrence at seven years, justifying the search for more effective treatment alternatives.
Collapse
Affiliation(s)
- Mahasti Saghatchian
- American hospital of Paris, department of medical oncology, Neuilly sur seine, France
| | - Elsa Curtit
- Jean-Minjoz university hospital, department of medical oncology, Besançon, France
| | - David Coeffic
- Courlancy polyclinic, department of medical oncology, Reims, France
| | - Alain Flinois
- Kantar health institute, department of oncology, Paris, France.
| | - Christelle Levy
- CRLCC François-Baclesse, department of medical oncology, Caen, France
| |
Collapse
|
43
|
Amrani Hassani Joutei H, Mahfoud W, Sadaoui I, Fechtali T, Benomar H. [Study of epidemiological clinical and pathological characteristics of gastric adenocarcinoma in a Moroccan population]. Ann Pathol 2020; 40:442-446. [PMID: 32532470 DOI: 10.1016/j.annpat.2020.04.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2017] [Accepted: 04/28/2020] [Indexed: 11/30/2022]
Abstract
Stomach cancer is essentially represented by gastric adenocarcinomas. It remains one of the world's top ten causes of death with a poor prognosis. The aim of our work is to describe the epidemiological characteristics of gastric adenocarcinoma through a retrospective, observational study over a period of one year. One hundred and twenty one cases were sent to the Pathology Laboratory of the IPM-Casablanca, 98 were selected for this study. There was a male predominance. Patients aged over 50 years represented the predominant age group (62%) (P-value=0.03). The average tumor size was 5,17±2,16cm, and most patients were diagnosed in the advanced TNM stage with a rate of 72.44%. In the absence of specific symptoms, gastric adenocarcinoma is a cancer of elderly, frequently diagnosed at a late stage, minimizing the chances of any curable treatment. The adoption of a screening policy in our area would probably be beneficial. Indeed, the benefit of annual screening at least among people aged over 50 years should be assessed.
Collapse
Affiliation(s)
- H Amrani Hassani Joutei
- Laboratoire d'anatomo-histo-pathologie, institut Pasteur-du-Maroc, 1, rue Louis-Pasteur, B.P. 20100 Casablanca, Maroc; Laboratoire de neurosciences pathologies intégrées et substances naturelles, faculté des sciences et techniques, B.P. 650 Mohammedia, Maroc.
| | - W Mahfoud
- Laboratoire d'anatomo-histo-pathologie, institut Pasteur-du-Maroc, 1, rue Louis-Pasteur, B.P. 20100 Casablanca, Maroc; Laboratoire de biologie et santé URAC 34, faculté des sciences Ben'Msik, B.P. 7955 Casablanca, Maroc
| | - I Sadaoui
- Laboratoire d'anatomo-histo-pathologie, institut Pasteur-du-Maroc, 1, rue Louis-Pasteur, B.P. 20100 Casablanca, Maroc; Laboratoire de génétique médicale, faculté de médecine et de pharmacie, B.P. 915 Casablanca, Maroc
| | - T Fechtali
- Laboratoire de neurosciences pathologies intégrées et substances naturelles, faculté des sciences et techniques, B.P. 650 Mohammedia, Maroc
| | - H Benomar
- Laboratoire d'anatomo-histo-pathologie, institut Pasteur-du-Maroc, 1, rue Louis-Pasteur, B.P. 20100 Casablanca, Maroc
| |
Collapse
|
44
|
Bachi F, Icheboudene K, Benzitouni A, Taharboucht Z, Zemmouri M. [Epidemiology of Cutaneous Leishmaniasis in Algeria through Molecular Characterization]. ACTA ACUST UNITED AC 2020; 112:147-152. [PMID: 31825568 DOI: 10.3166/bspe-2019-0087] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2019] [Accepted: 09/05/2019] [Indexed: 11/20/2022]
Abstract
Three distinct noso-epidemiological cutaneous leishmaniasis (LC) entities coexist in Algeria: the so-called sporadic form of the North (LCN), the zoonotic form (LCZ) and the chronic form (LCC). The precise identification of the parasitic species involved in each of the forms makes it possible to specify the geographical distribution of each of the forms raised, to distinguish their clinical aspects, to guide the therapeutic behaviors and to adapt the control programs. Ninety-seven (97) human strains from 97 cases of LC were subjected to molecular characterization by PCR-ITS1 followed by sequencing of this inter-gene space. Our results confirm the endemicity of the three forms. The LCN, caused by L. infantum (17 isolates/97 i.e. 17.52%) is limited to the North of the country mainly (16 isolates/17). Its geographical distribution is superimposable to that of visceral leishmaniasis with an extension more and more reported in previously unaffected areas, such as the regions of Tlemcen and Oran in the West, Setif, Annaba and Collo in the East. The LCZ, due to L. major (70 strains/97 i.e. 72.16%), remains the dominant form in the arid and semi-arid zones (47 strains/70) with a progression towards the North (20/70 strains). Indeed, long confined to the Sahara, it shows a geographical extension outside its historic homes of Biskra and Abadla. This form is progressing dangerously towards the highlands and the steppe regions of the country. The most interesting fact was the identification of L. tropica for the first time in North-Central and North-West Algeria in Algerian patients who had never left the national territory. Out of the 10 strains of L. tropica identified, 8 belonged to patients of Syrian origin and 2 to Algerian patients. L. tropica was reported for the first time in 2008 in 6 patients living in Constantine (North-East Algeria) and in 2017, still in the North-East of the country, in Annaba. The observation of L. tropica in the North and Northeast center of the country, where L. infantum and L. major coexist, suggests changes in the epidemiology of cutaneous leishmaniasis in Algeria, which highlights the interest of more investigations to better understand the transmission cycle of the different entities.
Collapse
Affiliation(s)
- F Bachi
- Laboratoire de biologie parasitaire, institut Pasteur d'Algérie, route du Petit-Staoueli, Dely-Brahim, Alger 16000, Algérie.,Département de médecine, faculté de médecine d'Alger, université d'Alger, 2, rue Didouche-Mourad, Alger Centre 16000, Algérie
| | - K Icheboudene
- Laboratoire de biologie parasitaire, institut Pasteur d'Algérie, route du Petit-Staoueli, Dely-Brahim, Alger 16000, Algérie
| | - A Benzitouni
- Laboratoire de biologie parasitaire, institut Pasteur d'Algérie, route du Petit-Staoueli, Dely-Brahim, Alger 16000, Algérie
| | - Z Taharboucht
- Laboratoire de biologie parasitaire, institut Pasteur d'Algérie, route du Petit-Staoueli, Dely-Brahim, Alger 16000, Algérie
| | - M Zemmouri
- Laboratoire de biologie parasitaire, institut Pasteur d'Algérie, route du Petit-Staoueli, Dely-Brahim, Alger 16000, Algérie
| |
Collapse
|
45
|
Leoni MC, Hau I, Biscardi S, Jung C, Delestrain C, Mangiapan G, Nattes E, Madhi F, Epaud R. [Antibiotic strategy in pleural empyema in children: Consensus by the DELPHI method]. Rev Mal Respir 2020; 37:443-50. [PMID: 32439250 DOI: 10.1016/j.rmr.2020.04.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2019] [Accepted: 04/11/2020] [Indexed: 11/22/2022]
Abstract
INTRODUCTION The evolution of the microbial epidemiology of pleuropulmonary infections complicating community-acquired pneumonia has resulted in a change in empirical or targeted antibiotic therapy in children in the post Prevenar 13 era. The three main pathogens involved in pleural empyema in children are Streptococcus pneumoniae, Staphylococcus aureus and group A Streptococcus. METHODS A questionnaire according to the DELPHI method was sent to experts in the field (paediatric pulmonologists and infectious disease specialists) in France with the purpose of reaching a consensus on the conservative antibiotic treatment of pleural empyema in children. Two rounds were completed as part of this DELPHI process. RESULTS Our work has shown that in the absence of clinical signs of severity, the prescription of an intravenous monotherapy is consensual but there is no agreement on the choice of drug to use. A consensus was also reached on treatment adjustment based on the results of blood cultures, the non-systematic use of a combination therapy, the need for continued oral therapy and the lack of impact of pleural drainage on infection control. On the other hand, after the second round of DELPHI, there was no consensus on the duration of intravenous antibiotic therapy and on the treatment of severe pleural empyema, especially when caused by Staphylococci. CONCLUSIONS The result of this work highlights the needed for new French recommendations based on the evolution of microbial epidemiology in the post PCV13 era.
Collapse
|
46
|
Macquart de Terline D, Kramoh KE, Bara Diop I, Nhavoto C, Balde DM, Ferreira B, Houenassi MD, Hounsou D, Ikama MS, Kane A, Kimbally-Kaki SG, Kingue S, Koffi F, Kouam Kouam C, Limbole E, Mfeukeu Kuate L, Mipinda JB, N'goran Y, Sesso Z, Sidi Aly A, Toure IA, Plouin PF, Azizi M, Perier MC, Narayanan K, Empana JP, Jouven X, Antignac M. Poor adherence to medication and salt restriction as a barrier to reaching blood pressure control in patients with hypertension: Cross-sectional study from 12 sub-Saharan countries. Arch Cardiovasc Dis 2020; 113:433-442. [PMID: 32434710 DOI: 10.1016/j.acvd.2019.11.009] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/06/2019] [Revised: 10/30/2019] [Accepted: 11/21/2019] [Indexed: 11/16/2022]
Abstract
BACKGROUND Sub-Saharan Africa is experiencing a rising burden of hypertension. Antihypertensive medications and diet are the cornerstone of effective hypertension control. AIMS To assess adherence to medication and salt restriction in 12 sub-Saharan countries, and to study the relationship between adherence and blood pressure control in patients with hypertension. METHODS We conducted a cross-sectional survey in urban clinics in twelve sub-Saharan countries. Data were collected on demographics, treatment and adequacy of blood pressure control in patients with hypertension attending the clinics. Adherence was assessed by questionnaires completed by the patients. Hypertension grades were defined according to European Society of Cardiology guidelines. Association between adherence and blood pressure control was investigated using multilevel logistic regression analysis, adjusting for age, sex and country. RESULTS Among the 2198 patients, 77.4% had uncontrolled blood pressure, 34.0% were poorly adherent to salt restriction, 64.4% were poorly adherent to medication and 24.6% were poorly adherent to both. Poor adherence to salt restriction (odds ratio [OR] 1.33, 95% confidence interval [CI] 1.03-1.72), medication (OR 1.56, 95% CI 1.25-1.93) or both (OR 1.91 1.39-2.66) was related to uncontrolled blood pressure. Moreover, poor adherence to both medication and salt restriction was related to a 1.52-fold (95% CI 1.04-2.22), 1.8-fold (95% CI 1.22-2.65) and 3.08-fold (95% CI 2.02-4.69) increased likelihood of hypertension grade 1, 2 and 3, respectively. CONCLUSIONS High levels of poor adherence to salt restriction and medication were noted in this urban sub-Saharan study; both were significantly associated with uncontrolled blood pressure, representing major opportunities for intervention to improve hypertension control in sub-Saharan Africa.
Collapse
Affiliation(s)
- Diane Macquart de Terline
- Sorbonne Université, AP-HP, Sorbonne Université, Hôpital Saint Antoine, Service de Pharmacie, 75012 Paris, France; Université de Paris, INSERM U970, Paris Cardiovascular Research Centre, Integrative Epidemiology of cardiovascular disease, Paris, France; Université de Paris, Paris, France.
| | | | | | | | - Dadhi M Balde
- Department of Cardiology, University Hospital of Conakry, Guinea
| | | | | | - Dominique Hounsou
- National University Hospital of Hubert K. Maga (CNHU-HKM), 01 BP 386, Cotonou, Bénin
| | - Méo Stéphane Ikama
- Cardiology Department, National University Hospital of Brazzaville, Marien Ngouabi University, Brazzaville, Congo
| | - Adama Kane
- Cardiology Department, University Hospital of Aristide Le Dantec, Dakar, Senegal
| | - Suzy Gisèle Kimbally-Kaki
- Cardiology Department, National University Hospital of Brazzaville, Marien Ngouabi University, Brazzaville, Congo
| | - Samuel Kingue
- University of Yaoundé, Ministry of Public Health, Cameroon
| | - Florent Koffi
- Institute of Cardiology of Abidjan, BPV 206, Abidjan, Côte d'Ivoire
| | | | - Emmanuel Limbole
- Department of Internal Medicine of la Gombe (CMCG), Ngaliema Hospital, Kinshasa, Democratic Republic of the Congo
| | | | | | - Yves N'goran
- Institute of Cardiology of Abidjan, BPV 206, Abidjan, Côte d'Ivoire
| | | | | | - Ibrahim Ali Toure
- Internal Medicine and Cardiology Department, University Hospital of Lamordé, Niamey University, Niamey, Niger
| | - Pierre François Plouin
- Université de Paris, INSERM U970, Paris Cardiovascular Research Centre, Integrative Epidemiology of cardiovascular disease, Paris, France; Université de Paris, Paris, France; Department of Cardiology, Georges-Pompidou European Hospital, AP-HP, 75015 Paris, France
| | - Michel Azizi
- Université de Paris, INSERM U970, Paris Cardiovascular Research Centre, Integrative Epidemiology of cardiovascular disease, Paris, France; Université de Paris, Paris, France; Department of Cardiology, Georges-Pompidou European Hospital, AP-HP, 75015 Paris, France
| | - Marie Cécile Perier
- Université de Paris, INSERM U970, Paris Cardiovascular Research Centre, Integrative Epidemiology of cardiovascular disease, Paris, France
| | | | - Jean Philippe Empana
- Université de Paris, INSERM U970, Paris Cardiovascular Research Centre, Integrative Epidemiology of cardiovascular disease, Paris, France
| | - Xavier Jouven
- Université de Paris, INSERM U970, Paris Cardiovascular Research Centre, Integrative Epidemiology of cardiovascular disease, Paris, France; Université de Paris, Paris, France; Department of Cardiology, Georges-Pompidou European Hospital, AP-HP, 75015 Paris, France
| | - Marie Antignac
- Sorbonne Université, AP-HP, Sorbonne Université, Hôpital Saint Antoine, Service de Pharmacie, 75012 Paris, France; Université de Paris, INSERM U970, Paris Cardiovascular Research Centre, Integrative Epidemiology of cardiovascular disease, Paris, France
| |
Collapse
|
47
|
Le Hello C, Fouillet L, Boulon C, Rivière S, El Jaouhari A, Seffert B, Morel A, Boissier C. [Lower-limb peripheral arterial disease]. Rev Med Interne 2020; 41:667-72. [PMID: 32359979 DOI: 10.1016/j.revmed.2020.03.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2020] [Accepted: 03/06/2020] [Indexed: 12/24/2022]
Abstract
Peripheral arterial disease is a result of atheroma. This disease is frequent in subjects with vascular risk factors. This disease is also frequent in low income countries. The detection and the diagnosis of peripheral arterial disease is obtained by calculating the ankle brachial index. Patients with peripheral arterial disease are not always symptomatic thus explaining how this disease is under diagnosed. The symptoms can be absent, and especially in case of diabetes or in women. In case of peripheral arterial disease, atheroma often involves other arterial vascular networks especially the coronaries. An adapted treatment reduces the morbi-mortality linked to this disease. This treatment is based on the correction of the vascular risk factors and especially tobacco cessation, walking rehabilitation and drugs (antiplatelet agent, statin, renin angiotensin system blocker). In case of rest or critic ischemia, the first-line treatment is a revascularisation. In peripheral arterial disease, management of patients is often non optimal and therapeutic targets fairly often obtained.
Collapse
|
48
|
Gestro M, Condemi V, Bardi L, Tomaino L, Roveda E, Bruschetta A, Solimene U, Esposito F. Short-term air pollution exposure is a risk factor for acute coronary syndromes in an urban area with low annual pollution rates: Results from a retrospective observational study (2011-2015). Arch Cardiovasc Dis 2020; 113:308-320. [PMID: 32359859 DOI: 10.1016/j.acvd.2020.03.013] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/11/2019] [Revised: 01/13/2020] [Accepted: 03/09/2020] [Indexed: 01/03/2023]
Abstract
BACKGROUND Epidemiological data suggest that air pollutants are risk factors for cardiovascular disease. Recent studies have questioned the adequacy of current legal pollutant limits, because concentrations lower than those recommended still affect cardiovascular morbidity and mortality. AIM To investigate the association between short-term exposure to air pollutants and the daily diagnosis of acute coronary syndrome (ACS) at the emergency department (ED) of S. Croce Hospital (Cuneo, Italy), between 2011 and 2015. METHODS We evaluated the effect of particulate matter (PM2.5-10), nitrogen dioxide and ozone as primary exposure, together with temperature and relative humidity as climatological control variables, on ED admissions for ACS (response variables). We studied residents aged ≥35 years, classified into three age groups (35-64, 65-74 and ≥75 years). Environmental data were analysed according to Poisson's regression, and conventional cardiovascular risk factors (CRFs; hypertension, diabetes, coronary artery disease, smoking and dyslipidaemia) were included as control variables. RESULTS ED admissions for ACS were 1625/391,689, with 298 in 2011 (0.183%), 305 in 2012 (0.188%), 347 in 2013 (0.214%), 341 in 2014 (0.21%) and 334 in 2015 (0.206%), with a general growth rate of 2.08% (from 2011 to 2015). The CRFs examined were confirmed to be highly associated with occurrence of ACS. Our study identified PM2.5 and temperature in all age groups to be additional risk factors, with PM2.5 exposure (P<0.01) being a particular risk for those aged ≥75 years. Dose-response models confirmed only PM2.5 as the main environmental risk factor in elderly patients (relative risk 1.06, 95% confidence interval 1.02-1.11; lag time 0-3 days). We also found a consistent relative risk for temperature in all age groups. CONCLUSION This study confirms the importance of PM2.5 as a risk factor for ACS, mostly in elderly patients, even in a city with low annual pollution rates.
Collapse
Affiliation(s)
- Massimo Gestro
- Department of Biomedical Science for Health, University of Milan, Via Colombo 71, 20133 Milano, Italy
| | - Vincenzo Condemi
- Department of Biomedical Science for Health, University of Milan, Via Colombo 71, 20133 Milano, Italy.
| | - Luisella Bardi
- Cuneo Department, Environmental Protection Agency of Piedmont, 10135 Turin, Italy
| | - Laura Tomaino
- Department of Clinical Science and Community Health (DISCCO), University of Milan, 20122 Milan, Italy
| | - Eliana Roveda
- Department of Biomedical Science for Health, University of Milan, Via Colombo 71, 20133 Milano, Italy; IRCCS Istituto Ortopedico Galeazzi, 20161 Milan, Italy
| | | | - Umberto Solimene
- Department of Biomedical Science for Health, University of Milan, Via Colombo 71, 20133 Milano, Italy
| | - Fabio Esposito
- Department of Biomedical Science for Health, University of Milan, Via Colombo 71, 20133 Milano, Italy; IRCCS Istituto Ortopedico Galeazzi, 20161 Milan, Italy
| |
Collapse
|
49
|
Bouhanick B, Cracowski JL, Faillie JL. [Diabetes and COVID-19]. Therapie 2020:S0040-5957(20)30068-8. [PMID: 33965234 PMCID: PMC7194540 DOI: 10.1016/j.therap.2020.04.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
According to previous reports, diabetes seems to be associated with serious clinical events due to COVID-19. But is diabetes per se a risk factor of being infected by the virus? We discuss these points. Data about the antidiabetic drugs are scarce. Dipeptidylpeptidase-4 (DPP-4) is found as both a cell surface protein ubiquitously expressed in many tissues and as a soluble molecule found in serum/plasma, fluids. DPP-4 is involved in infection of cells by some viruses. We relate data about the use of DPP-4 inhibitors in diabetic patients. We conclude relating French and international recommendations in people with diabetes.
Collapse
Affiliation(s)
- Béatrice Bouhanick
- Pôle cardiovasculaire et métabolique, service d'HTA et de thérapeutique, CHU Rangueil, TSA 50032, 1, avenue J.- Poulhes, 31059 Toulouse cedex 9, France; UMR 1027, université Toulouse III, 31000 Toulouse, France.
| | - Jean-Luc Cracowski
- Centre régional de pharmacovigilance de Grenoble, université Grenoble Alpes, CHU Grenoble, 38000 Grenoble, France.
| | - Jean-Luc Faillie
- Département de pharmacologie médicale et toxicologie, Centre régional de pharmacovigilance Occitanie-Est, CHU Montpellier, 371, avenue du Doyen Gaston Giraud, 34295 Montpellier, France.
| |
Collapse
|
50
|
Amad A, Magnat M, Quilès C, Yrondi A, Sauvaget A, Bulteau S, Plaze M, Rotharmel M, Polosan M, Lévy-Chavagnat D, Jaafari N, Vaiva G, Thomas P. [Evolution of electro-convulsive therapy activity in France since the beginning of the COVID-19 pandemic]. Encephale 2020; 46:S40-S42. [PMID: 32370981 PMCID: PMC7174183 DOI: 10.1016/j.encep.2020.04.004] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/09/2020] [Accepted: 04/10/2020] [Indexed: 12/03/2022]
Abstract
La pandémie récente de COVID-19 a entraîné des changements organisationnels majeurs dans les lieux de soins et notamment en hospitalisation en psychiatrie. Pour évaluer l’évolution de l’activité des différents centres pratiquant l’ECT, une enquête nationale en ligne a été réalisée. 65 réponses de toute la France ont été analysées. Plus de 90 % des centres pratiquant l’ECT ont connu une diminution de leur activité. Plus inquiétant encore, la moitié des centres ont subi un arrêt total de leur activité et un quart des centres accusent une diminution de plus de la moitié de leur activité habituelle. Les soins psychiatriques post-pandémie COVID-19 s’annoncent difficiles. Il est essentiel de ne pas ajouter à cette difficulté les complications, souvent graves, qui seront liées au retard ou à l’arrêt de la pratique de l’ECT. Il conviendra aussi de rester vigilant quant aux conséquences spécifiques neuropsychiatriques qui feront suite à la pandémie.
Collapse
Affiliation(s)
- A Amad
- Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France.
| | - M Magnat
- Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France
| | - C Quilès
- Centre hospitalier Charles-Perrens, 33000 Bordeaux, France
| | - A Yrondi
- Service de Psychiatrie et de Psychologie Médicale, Centre Expert Dépression Résistante FondaMental, CHU de Toulouse, Hôpital Purpan,ToNIC Toulouse NeuroImaging Center, Université de Toulouse, INSERM, UPS, Toulouse, France
| | - A Sauvaget
- Nantes Université, CHU Nantes,Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes, France
| | - S Bulteau
- Nantes Université, CHU Nantes,Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes, France
| | - M Plaze
- Université de Paris, 75005 Paris, France; Service Hospitalo-Universitaire, GHU Paris Psychiatrie & Neurosciences, 75014 Paris, France
| | - M Rotharmel
- Service Hospitalo-Universitaire-Unité START, Centre Hospitalier du Rouvray, Sotteville-lès-Rouen, France
| | - M Polosan
- Université Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, GIN, 38000 Grenoble, France
| | - D Lévy-Chavagnat
- Unité de recherche clinique, université de Poitiers, centre hospitalier Henri-Laborit, 370, avenue Jacques-Cœur, CS10587, 86021 Poitiers cedex, France
| | - N Jaafari
- Unité de recherche clinique, université de Poitiers, centre hospitalier Henri-Laborit, 370, avenue Jacques-Cœur, CS10587, 86021 Poitiers cedex, France
| | - G Vaiva
- Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France
| | - P Thomas
- Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France
| |
Collapse
|